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Thesis Abstract 
The aim of this study was to investigate the quality of service delivery for HIV-infected women at 
antenatal clinics in two provinces in South Africa and to highlight areas for improvement. 
The specific objectives were to: 
• Describe the quality of care at antenatal facilities in the context of expected standards according
to national guidelines.
• Ascertain patient satisfaction with services and health education.
• Determine whether quality of care is linked to resources.
• Determine whether patient perceptions of quality of care are influenced by the resources
available and services rendered.
This study was conducted as part of a larger study to determine the effectiveness of PMTCT 
programmes in 4 countries. In South Africa, the Western Cape and Free State provinces were selected 
because the researchers had access to facilities in these provinces. These provinces were also different 
in terms of socio-demographic make-up and resources available. Three areas which translated to health 
sub-districts were randomly selected in each province.  
This was a cross-sectional study design with provider-patient clinical observations, structured provider 
interviews and patient exit interviews.  
The population included all clinics with antenatal services in the Western Cape and Free State. Pregnant 
women attending these antenatal services and health care providers at these services were selected 
from these clinics to assess care at these services.  The sampling frame for the facility survey consisted 
of the antenatal clinics that referred patients to the delivery sites where the first component of the 
PEARL study, a cord blood surveillance exercise had taken place. Clinics with the largest number of 
attendees in the three sub-districts in each province were chosen.   
Five sites from the Western Cape and 13 sites from the Free State were selected for the facility survey. A 
convenience sample of 6 consecutive women attending the service was selected from the list of 
attendees at the antenatal service on that particular day and exit interviews were conducted with those 
women.  In addition, at each of the facilities field workers observed consultations with six women other 
than those who participated in the exit interviews. An interview was also conducted with the health care 
provider in charge of the antenatal service on the day of the survey. Informed consent was obtained 
from both the pregnant women and the providers. Data were collected between October 2008 and May 
2009 in the two provinces. Ethics approval was granted by the Health Sciences Faculty Research Ethics 









The PMTCT Effectiveness in Africa: Research and Linkages to Care (PEARL) facility survey constituted one 
of three components of a larger study which sought to evaluate the effectiveness of PMTCT 
programmes in 4 countries, including South Africa.  
 
Data were collected between October 2008 and May 2009, prior to the analysis and write up of the 
facility survey by by clinically trained field workers.  
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Part A: Protocol 
 
Part I:  Introduction 
 
 
Problem   
 
Global evidence suggests that there has been uneven progress made towards attaining the United 
Nations Millennium Development Goal 5 targets of reducing maternal mortality and improving universal 
access to reproductive health care by 2015. Challenges  remain due to limitations in the provision of 
maternity services, barriers to accessing emergency obstetric care and the education of women around 
maternal health.1 According to the fourth ‘Saving Mothers’ report (2005-2007) almost 60% of maternal 
deaths in South Africa  were avoidable and over half of these deaths were attributed to health systems 
failures. 2 In addition, the ‘Saving Babies’ report for 2006-2007 found that the quality of perinatal care in 
district hospitals was poor, and over one third of perinatal deaths were due to avoidable health system 
failures. 3 The ‘Saving Mothers’ report attributed failures to a lack of health care facilities, poor transport 
to or between facilities, a lack of appropriately trained staff, non-adherence to standard operating 
protocols, poorly conducted initial assessment of patients and poor problem recognition. 2  
 
The report highlights the need for staff training and support from government and non-governmental 
agencies with an accountability system in place to ensure the quality of health services. The report 
further recommends that interventions be introduced to address knowledge development, quality of 
care, coverage, the establishment of norms and standards and community engagement. Interventions 
should include training in emergency care as well as screening for and treatment of the major risk 
factors associated with maternal mortality and the appropriate provision and management of staff, 
equipment and transport.2 
 
The provisions of the South African National Health Act of 2003 and the Policy for Quality set 
recommendations for performance and accountability. Some of the aims set by government outlined in 
the Policy for Quality Health Care to improve the standard of care delivered include: assessing issues of 
access, increasing patient participation, a focus on preventive and promotive activities, increasing 
research on operational effectiveness, ensuring appropriate use of health care services and reducing 
adverse events in the health care setting. The four main target groups of the interventions included 
health professionals, patients, the community and the health service delivery system.4  
 
Despite these recommendations, research in South Africa suggests that there are a number of factors 
that continue to impact on the quality of antenatal care (ANC) services. Studies have focussed on 
elements of service management and delivery, including the training of health professionals; staff 
morale; patient waiting times; as well as the privacy of patient-provider interactions and 
comprehensiveness of consultations. The lack of privacy at many facilities and the fact that patients 
often see a number of different providers during their visit adversely impacts on good communication 
and the fostering of a good client-provider relationship. Consequently many women find it difficult to 
discuss personal problems and concerns. 5 A study conducted in Kwazulu Natal found that in spite of 
women arriving early for their antenatal appointments and spending many hours at the facility, women 






average 4.5 hours in the facility, 4 of which is spent waiting to see a provider.6 Despite the evidence 
suggesting concerns around quality of care, many studies have reported that women are generally 
satisfied with the quality of ANC. 7 This may be due to low expectations amongst users of the services, or 
social desirability bias.7 
 
In a study on quality of care at contraceptive services, 20% of women reported that the provider scolded 
them. 8 Poor quality of care may be related to low morale amongst health care providers. A nursing 
dynamics study found that 27% of nurses reported that they did not care for patients like they used to 
while 60% felt a lack of motivation to work as hard. 9 The nurses attributed the low level of motivation to 
limited opportunities for promotions, poor management as well as staff shortages. 9 A five year review 
of the public sector carried out in 1999 also found that the morale amongst staff was very low, 
especially among nurses. Although the nurses attributed low morale to being overworked, feelings of 
neglect and lack of support is also believed to have contributed.10 It is thought that the morale of health 
workers will improve by fostering a sense of purpose and personal fulfilment; this could be facilitated 
through the articulation of a clear vision and plan by national and provincial managers.11  
 
Service delivery and quality of health care are contingent on a well functioning health system.12The 
transformation of the South African health system after 1994 including the implementation of a primary 
health care system has been challenged due to a wide range of factors including high rates of medical 
migration, health worker shortages, an inequitable distribution of resources and personnel, poor 
leadership and managerial capacities in the health system. Health service delivery is further challenged 
by a complex and evolving burden of disease. The rapid progression of the HIV epidemic has 
necessitated the introduction of comprehensive health services as well as widespread preventive 
interventions.13 Consequently, the increasing demands on primary health care services and the 
expanding scope of practice of nurses who provide the backbone of primary health care must be 
managed with strong leadership and stewardship to ensure the successful implementation of proposed 
HIV-related polices. 
 
According to UNAIDS, approximately 370 000 children were infected with HIV in 2007, 90% of infections  
being due to vertical transmission from mother to child, with  90% of these infections occurring in Sub 
Saharan Africa. 14 Over one third of childhood deaths were caused by HIV in high prevalence countries 
including South Africa in 2007, 13 severely threatening the gains made in child survival. As a response, 
the South African government has rapidly implemented the programme for the prevention of mother-
to-child transmission of HIV (PMTCT). Through introduction of voluntary counselling and testing (VCT) 
and the provision of ARV regimens at antenatal services, the PMTCT programme is often the gateway to 
HIV care for pregnant women and their families.15 PMTCT services in South Africa began as a pilot 
service in early 1999.16,17 before being rolled out nationally in 2001. 
 
PMTCT programmes have reduced transmission rates from 40% to less than 5% in research settings in 
sub Saharan Africa. 8 National governments, following the United Nations General Assembly in 2001, 
committed themselves to reducing the proportion of infants infected with HIV in half by 2010 by 
ensuring that 80% of women in need access PMTCT services.18 Operational data collected for 2008 have 
shown that approximately 50% of HIV-infected women had access to PMTCT services in South Africa19 







PMTCT requires a number of steps including voluntary HIV counselling and testing during antenatal care. 
Basic obstetric services need to deliver antiretroviral therapy to HIV-infected pregnant women, ensure 
safe deliveries and provide counselling on infant feeding. Post partum care includes infant feeding 
support, growth monitoring, family planning, the screening of children for HIV and long term support to 
infected mothers and their families. This is known as the PMTCT cascade and process indicators can be 
collected at each point. Many studies assessing programme coverage have documented attrition along 
each step of the cascade.20 Reasons for non-acceptance of testing or prophylaxis vary across settings, 
but may be related to poor understanding amongst pregnant women, denial or fear of stigma. 21 Other 
factors include service-related barriers to care. A study conducted to assess the operational 
effectiveness of PMTCT programmes across three districts in South Africa found the overall quality of a 
particular health service explained some of the differences seen in HIV transmission rates and death 
across the sites. Although utilisation of antenatal services was high across the sites, syphilis testing and 
the uptake of nevirapine was poor.22  Programme evaluations from a number of countries in Africa 
found failures at each point along the PMTCT cascade including uptake of antenatal testing,23, 24 receipt 
of test results, 25uptake of ARVs 26, 27, 28 and postnatal follow up.22  In 2006-2007, South African antenatal 
service coverage was 90%5 yet HIV testing rates were 69%29. Furthermore, one third of HIV-infected 
women did not receive nevirapine at delivery, 2 although 84% of all births were assisted by trained 
health personnel.5 
 
According to the ‘Saving Mothers’ report, 59% of mothers who died had been tested for HIV with 79% 
testing HIV-positive from 2005-2007, an increase from 46% in the previous triennium when 78% tested 
HIV-positive. Where antenatal care status was known, 76% of those who died during or within 6 weeks 
of pregnancy had attended antenatal clinics. This was lower than the overall coverage of 95%. 2 This 
highlights the need to focus on health system interventions to improve maternal mortality.  The report 
also highlights the notable shift in cause of maternal deaths to non-pregnancy related infection, in 
particular due to AIDS2; many of these deaths could have been avoided through PMTCT interventions.  
 
The integration of PMTCT programmes into health systems that are overburdened and under resourced 
may have contributed to the sub-optimal outcomes seen.30In order to minimize attrition along the 
PMTCT cascade, compassionate staff within well functioning antenatal, intrapartum and postpartum 
services with good laboratory support and referral services are required. In addition the services need to 
be well resourced and have a reliable source of tests and medications such as ARVs as well as a 




The Women’s Health and Genetics Directorate is responsible for the antenatal care programme in South 
Africa. A set of guidelines and policy documents were produced by the Department of Health and 
include the maternal health policy outlining the minimum set of requirements for rendering maternal 
health care services.  The guidelines discuss the management of pregnant women and the service 
provision to be rendered at each level of care. In addition, the guidelines define the levels of care, the 
staffing requirements at each level, the services to be provided and the referral systems to be put in 
place. While the National Maternity Guidelines outline how maternity services should be provided, each 
province is expected to adapt the guidelines according to local conditions and needs. A system in place 
to assess whether all the facilities have and are using the guidelines is lacking, however.  An assessment 
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of 141 public sector PHC facilities nationally found that the national guidelines could only be found in 
46% of the facilities. 32 
The maternity guidelines outline the elements of care and procedures to be provided during the first 
and subsequent visits. The main components of antenatal care include: registration, group counselling, 
urine testing, blood pressure and weight measurements, pre-test counselling and testing for HIV, full 
history taking, blood sample collection, an examination, and the provision of medication.33 In 2000, the 
National Primary Health Care Facility Survey found that only 87.4% of clinics provided antenatal care, 
and the services were not provided daily. 34 Subsequent to these findings, the National Health Act 
stipulates that the delivery of all health services is the responsibility of the provincial health department 
and  antenatal care should be routinely provided to low risk women at all primary health care facilities. 
Yet other research has shown that many facilities still restrict visits to certain days of the week.6 
Antenatal services rendered should be recorded so as to ensure adherence to guidelines, although a 
number of studies have found that this is not the case. 35, 6, 7 
Surveys have commonly been used to evaluate health services. The eight main facility-based assessment 
tools currently used at both national and programme levels worldwide include the Service Provision 
Assessment (SPA), Facility Audit of Service Quality (FASQ), Health Facility Census (HFC), Service 
Availability Mapping (SAM), Health Facility based survey of Human Resource for Health Services (HRHS), 
Rapid Health Facility Assessment in Child Health (Rapid HFA), Access, Quality, and Use in Reproductive 
Health (ACQUIRE) Evaluation of LAPM Services (ELMS); and Population Council Health Facility 
Assessment (PCHFA).36 
The tools allow for the evaluation of a wide range of elements related to service provision so as to 
inform policy and planning at the national, provincial and district level worldwide in order to improve 
the delivery of care. Information collected includes the documentation of resource systems and 
practices in place, the quality of care delivered, information on the functionality of the physical assets of 
the health sector including infrastructure and equipment, and the state of the health workforce 
including the workforce profiles and projections of need. Some tools have been developed to specifically 
target particular services, including the AQUIRE Evaluation of LAPM Services (ELMS) focusing on Family 
Planning/Long Acting and Permanent Methods (FP/LAPM) services, the Population Council HFA (PCHFA) 
focusing on reproductive health services and the R-HFA focusing on maternal newborn and child health 
services at the primary health care level. This R-HFA tool has been used for the piloting of interventions 
for service quality improvement in Africa and Asia.36 
Despite the availability of a wide range of measurement tools, few evaluations of antenatal care services 
have been conducted in South African settings.  A national HIV prevalence population survey from 2008 
conducted by the Human Sciences Resource Council found that 97% of women had access to antenatal 
care while pregnant with 71.4% attending at least five antenatal visits. In addition, the study found that 
the majority of pregnant women were attended to by a skilled birth attendant during labour. 37 Despite 
this, maternal mortality remains high according to the Saving the Mothers Report, which suggests that 
challenges to delivering high quality care still subsist and that the quality of ANC services needs further 
evaluation. 






modified version of the above mentioned “Rapid Health Facility Assessment Tool: To Enhance Quality 
and Access at the Primary Health Care Level.” The PEARL Facility Survey, on which this analysis is based, 
was conducted in two provinces in South Africa, as well as in 3 other African countries. It constituted 
one of three components of a study which sought to evaluate the effectiveness of PMTCT programmes 
by measuring coverage of PMTCT services and evaluating clinic level factors impacting on this coverage, 
including the quality of antenatal care. The PEARL facility survey aimed to monitor adherence to national 
and provincial antenatal guidelines as a means to assess operational effectiveness and gaps in the 
provision and quality of services, including the PMTCT service.  Assessments of the quality of health 
services are essential for the strengthening of health systems. 
 
Aim and Objectives   
 
The aim of this study was to investigate the quality of service delivery for pregnant women at antenatal 
clinics in two provinces in South Africa and to highlight areas for improvement. 
 
The specific objectives were to: 
• Describe the quality of care at antenatal facilities in the context of expected standards according 
to national guidelines. 
• Ascertain patient satisfaction with services and health education.  
• Determine whether quality of care is linked to resources. 
• Determine whether patient perceptions of quality of care are influenced by the resources 
available and services rendered. 
 
Part II:  Methods 
 
As described above, this study was conducted as part of a larger study to determine the effectiveness of 
PMTCT programmes in 4 countries. In South Africa, the Western Cape and Free State provinces were 
selected because the researchers had access to facilities in these provinces. These provinces were also 
different in terms of socio-demographic make-up and resources available. Three areas which translated 




This was a cross-sectional study design with provider-patient clinical observations, structured provider 
interviews and patient exit interviews.  
 
Population and sampling  
 
The population included all clinics with antenatal services in the Western Cape and Free State. Pregnant 
women attending these antenatal services and health care providers at these services were selected from 
these clinics to assess care at these services.   
 
Method of sampling 
 






delivery sites where the first component of the PEARL study, a cord blood surveillance exercise had 
taken place.38 Clinics with the largest number of attendees in the three sub-districts in each province 
were chosen.   
 
Five sites from the Western Cape and 13 sites from the Free State were selected for the facility survey. A 
convenience sample of 6 consecutive women attending the service was selected from the list of attendees 
at the antenatal service on that particular day and exit interviews were conducted with those women.  In 
addition, at each of the facilities field workers observed consultations with six women other than those who 
participated in the exit interviews. An interview was also conducted with the health care provider in charge 
of the antenatal service on the day of the survey. Informed consent was obtained from both the pregnant 




Instruments   
 
The facility survey collected a range of information on antenatal services and the PMTCT programme. 
This included the type of facility, catchment area and location. The survey was divided into 4 modules.  
The first module constituted the direct observation of a consultation of the quality of clinical care. The 
second was an exit interview with women attending the facility, in order to measure perceptions and 
knowledge of care.  The third was a health facility assessment using a checklist to document 
infrastructure, equipment and drugs. Finally an interview with the health facility manager regarding 
services provided at the health facility and the human resources involved in the services was conducted. 
All components of the survey were conducted by clinically trained field workers. Exit interviews with 
patients were carried out in the patient’s mother tongue, while health care provider interviews were 
carried out in English or another African language (isiXhosa, Afrikaans, or SeSotho) where applicable. 
 
Validity and reliability of instruments. 
 
The survey instrument was pretested prior to data collection.  
 




All data were entered electronically into a Microsoft Access database. Data were cleaned in Access 
through cross checking a 10% sample of electronic entries against the hard copy version. Consistency 
checks were run to ensure accuracy of the data entered. The database was imported to STATA statistical 




For the purposes of this analysis, the facility survey content will be divided into three analytical domains, 
defined by the investigators as structure, process and outcome attributes. The structure domain will 
include physical attributes of health facility, availability of equipment, stock outs, human resources and 
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supervision, peer review, training and organizational structure. The process domain will include the 
health care worker conduct and competence. Outcome attributes will include patient satisfaction and 
understanding of their drug prescription. This framework for the analysis drew from Donabedian, who 
developed the principle of quality in health care and operationalized quality evaluation in health service 
settings.39 This approach has subsequently been more widely adopted in other developing contexts.40, 41, 
42, 43
Since the facility survey tool was designed to be used across four different country service settings, it 
contains some variables which are not pertinent to the South African ANC service context. Hence the 
choice of variables to be included for analysis will be based on an extensive literature review on the 
quality care in antenatal services including the minimum basic requirements for rendering care, as well 
as advice from local experts working in maternity services or PMTCT research. Certain variables deemed 
irrelevant will be omitted, for example the provision of anti-malarials which is not applicable in the 
Western Cape and Free State provinces. Furthermore, because some of the facilities had a labour ward 
while others were Basic Antenatal Care (BANC) sites which referred to larger establishments for delivery, 
items relating to delivery and newborn care including immunisation will also be omitted. 
Most variables were binary; however a few variables were continuous. Patient satisfaction was 
measured on a Likert scale from 1 to 5.  
Describing the data 
A univariate and bivariate analysis will be performed to assess the distribution of variables and how they 
differ across the provinces. Provinces will be compared using point and confidence interval estimates of 
the prevalence of facility attributes and activities conducted. For the purposes of comparison, variables 
that are patient specific, such as tests performed on the individual women during the consultation, will 
be aggregated by facility and proportions will be used to compare the provinces.  
Deriving an outcome score 
The outcome variable is patient satisfaction. Patient satisfaction will be measured from an average score 
for each facility from a number of different Likert items. The patient scores will be derived from the exit 
interviews in which the women attending the facilities were asked to respond on a Likert scale of 1-5 
ranging from ‘strongly disagree’ to’ strongly agree’ how they felt about a series of statements 
concerning the care they received on the day the survey was conducted. In order to derive a patient 
satisfaction score, scores obtained on each of the 16 questions will be added up, and averaged across 
the 6 women from each facility, to get an average satisfaction score for each site. The ordering for the 
positively loaded statements will be reversed relative to the negative ones, so that a higher score will 
reflect a higher level of satisfaction.  
Regression 
In order to identify relationships between predictor variables and the outcome, multiple linear 
regression will be used because the outcome score is a continuous variable. The rationale behind the 






difference in their values across the provinces or elements that have come through in the literature as 
influential contributors to quality of antenatal care and patient satisfaction.  
 




Ethical Consideration  
Ethical approval for this study was obtained from the UCT Human Research Ethics Committee in September, 
2008 (REC Ref 038/2007). This study will be conducted according to Good Clinical Practice (GCP) guidelines, 
the 2000 Declaration of Helsinki, local rules and South African ethical regulations (World Medical 
Association 2000).  
Quantitative Data Collection- Protection of privacy and confidentiality 
 
No personal identifiers were attached to any data collected. The only identifier collected was the name 
of the facility surveyed. All data collected is kept in secure and confidential files in the Centre for 
Infectious Disease Epidemiology and Research, School of Public Health and Family Medicine, UCT. No 
individual facility identifying information will be disclosed in reports, publications, or presentations.  
Qualitative data collection – Consent Procedures 
 
Written informed consent was obtained from all clinic attendees and health care providers involved in 
the qualitative data collection. The informed consent explained: 
        the purpose of the study; 
        the voluntary nature of participation;  
        what was involved in participation, including the duration of the interview; 
        the risks and benefits of participation; 
        protection of participant privacy (ie, that all information provided will be completely                       
confidential and will only be viewed and used by the researchers on this project, and that 
participants’ names will not be recorded to ensure anonymity); and, 
        the participant’s right to decide not to participate, to refuse to answer any question, or                   
to withdraw from the interview at any time without any penalty.  
 
Informed consent documents are presented in the Appendix.  
 
Risks and benefits of participation 
 
The only risk of participation for clinic attendees and providers in the semi-structured in-depth 
interviews and clinic observations was the potential risk of loss of privacy. Steps were taken to ensure 
the protection of confidentiality in order to minimize this possibility. There were no guaranteed benefits 
to individual participants for their participation; however, it was expected that participation in this study 
could help to inform and improve the quality of both antenatal and ongoing health care services for 





The results of this study will be communicated to the Department of Health and the Women’s Health 
and Genetics Directorate, community based or non-governmental organisations working in the area of 
maternal and child health, health care workers providing maternal and child health related services 
including PMTCT services, and women attending antenatal clinics. 
Reporting and implementation   
This study will be submitted for publication in a peer-reviewed journal. 
Part V: Logistics 
Timetable 
The study has already been completed and therefore this section is not applicable. 
Budget 
The study has already been completed and therefore this section is not applicable. 
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Part B: Literature Review 
Objectives 
The objective of this literature review was to summarise research that has evaluated ANC services and 
quality of maternal health care, as well as studies relating to patient satisfaction. Accessibility and 
utilisation of PMTCT programmes were also reviewed.  Since the quality of maternal health care 
influences maternal and child health outcomes; trends and predictors of maternal and child mortality 
were also reviewed.  
Search strategy and quality criteria 
The literature review focused on health systems evaluation of ANC and PMTCT programmes and 
services. This review included observational studies as randomized control trials (RCTs) are rarely used 
to assess outcomes such as patient satisfaction, following the introduction of new models of antenatal 
care. Data from systematic reviews of factors associated with patient satisfaction and patient outcomes 
were also assessed.  The review was restricted to articles and documents published in English since 
1990.  PubMed, Embase, and Google Scholar were searched in addition to hand searching the 
bibliographies of selected peer reviewed articles. Key words for the search criteria included ‘Quality’, 
‘Antenatal Care’, ‘South Africa’, ‘Maternal and Child mortality’, ‘PMTCT’, ‘Coverage’, and ‘Patient 
Satisfaction’. Abstracts of retrieved articles were read and if they were pertinent to the research 
question, full texts were then retrieved. Due to the dearth of information related to the topic, inclusion 
criteria were broad so as to ensure a comprehensive understanding of quality of antenatal care. As the 
fields of antenatal care and specifically PMTCT interventions are rapidly changing, data were drawn from 
national policy and treatment guidelines as well as health information systems. Since data for the study 
were collected between October 2008 and May 2009 in two provinces in South Africa, data reviews of 
primary health care and antenatal services focused on that period and prior so as to describe changing 
trends in the quality of care. In order to assess adherence to national and provincial antenatal and 
PMTCT guidelines and quality of care recommendations, the Department of Health website was 
accessed to retrieve appropriate resources, in addition to conducting a targeted web-based search of 
reported literature from select sites including Health Systems Trust, the World Health Organization 
(WHO) and the Joint United Nations Programme on HIV AIDS (UNAIDS) to retrieve information from 
health management information systems. 
Summary 
Maternal and Child Health 
Global evidence suggests that there has been uneven progress towards attaining the United Nations 
Millennium Development Goals (MDGs) of reducing maternal and child mortality and improving 
universal access to reproductive health care by 2015.1 Global mortality of children under the age of 5 
years has fallen from 12.5 million deaths in 1990 to 8.8 million in 2008.2 Despite this, neonatal mortality 
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still accounts for 41% of deaths in children under the age of 5 years1.  In 2008, 342 900 maternal deaths 
occurred worldwide ; 50% of these occurring in six countries, 3 of which were in Africa.3  An analysis  of 
progress made towards the Millennium Development Goals concluded that HIV is one of the main 
reasons for not reaching targets.4  Furthermore, it is estimated that maternal mortality would be 20% 
lower in the absence of HIV/AIDS.5  In 2001, the United Nations General Assembly Special Session 
(UNGASS) clearly emphasised the detrimental effects of HIV/AIDS on maternal and child health. 6  In the 
final declaration national governments committed themselves to reducing the proportion of infants 
infected with HIV by half by 2010 by ensuring that 80% of women in need access PMTCT services.6  
The need for HIV related services is of particular concern in South Africa which has the highest number 
of infections worldwide. As a response, the South African government has rapidly implemented the 
programme for the prevention of mother-to-child transmission of HIV (PMTCT). The introduction of 
voluntary counselling and testing (VCT) and the provision of ARV regimens at antenatal services as part 
of the PMTCT programme  provides  a gateway to HIV care for pregnant women and their families.7 
PMTCT services in South Africa began as a pilot service in early 19998,9 before being rolled out nationally 
in 2002.  
The quality of antenatal care services and the successful integration of the PMTCT programme are 
important contributors to better maternal and child health outcomes. According to the fourth ‘Saving 
Mothers’ report (2005-2007) almost 60% of maternal deaths in South Africa  were avoidable and over 
half of these deaths were attributed to health systems failures. 10 In addition, the ‘Saving Babies’ report 
for 2006-2007 found that the quality of perinatal care in district hospitals was poor, and over one third 
of perinatal deaths were due to avoidable health system failures11 .The ‘Saving Mothers’ report 
attributed failures to a lack of health care facilities, poor transport to or between facilities, a lack of 
appropriately trained staff, non-adherence to standard operating protocols, poorly conducted initial 
assessment of patients and poor problem recognition.10 
The ‘Saving Mothers’ report also found that 59% of mothers who died had been tested for HIV with 79% 
testing HIV-positive from 2005-2007. Where antenatal care status was known, 76% of those who died 
during or within 6 weeks of pregnancy had attended antenatal clinics.10 This was lower than the overall 
coverage of 95%. 10 This highlights the need to focus on health system interventions to improve 
maternal mortality.  The report also highlights the notable shift in cause of deaths to non-pregnancy 
related infection, in particular due to HIV infection. Many of these deaths could have been avoided 
through PMTCT interventions that allow the provision of ARVs to pregnant mothers and contribute to 
reductions in the vertical transmission of HIV10. Coverage indicators for maternal health interventions 
including skilled birth attendance, antenatal care and contraceptive prevalence further highlighted the 
magnitude of efforts needed to meet the Millennium Development Goals. Challenges still persist due to 
limitations in the provision of maternity services, barriers to accessing emergency obstetric care, the 
education of women around maternal health1, in addition to the burden of HIV. 
Organizational Structure of Maternity Services in South Africa 
The Women’s Health and Genetics Directorate of the National Department of Health is responsible for 
the co-ordination of the antenatal care programme in South Africa. A set of guidelines and policy 
documents was produced by this Directorate and include the maternal health policy outlining the 
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minimum set of requirements for rendering maternal health care services.  The guidelines describe the 
recommended management of pregnant women and the services to be rendered at each level of care. 
In addition, the guidelines define the levels of care, the staffing requirements at each level, the services 
to be provided and the referral systems to be put in place. While the National Maternity Guidelines 
outline how maternity services should be provided, each province is expected to adapt the guidelines 
according to local conditions and needs. The maternity guidelines outline the elements of care and 
procedures to be provided. The main components of antenatal care include: registration, group 
counselling, urine testing, blood pressure and weight measurements, pre-test counselling and testing for 
HIV, full history taking, blood sample collection, a clinical examination, and the provision of 
medication.12 
The PMTCT programme 
PMTCT services are integrated with ANC care. PMTCT requires a number of steps including voluntary 
HIV counselling and testing during antenatal care. Antenatal and obstetric services need to diagnose and 
treat opportunistic infections, deliver antiretroviral therapy to HIV-infected pregnant women, ensure 
safe deliveries and provide counselling on infant feeding. Post partum care includes infant feeding 
support, growth monitoring, family planning, the screening of children for HIV and long term support to 
infected mothers and their families. This is known as the PMTCT cascade and process indicators can be 
collected at each point. 13 
Framework for the Quality of Care 
It is recognized that a national focus on the quality of health care is imperative.14 The Institute of 
Medicine in the United States developed the now widely accepted definition of quality:  “Quality of care 
is the degree to which health services for individuals and populations increase the likelihood of desired 
health outcomes and are consistent with current professional knowledge.”14 
A framework used in this analysis of the quality of health services drew from Donabedian, who 
developed the principle of quality in health care and operationalized quality evaluation in health service 
settings.15This approach has subsequently been more widely adopted in other developing contexts.16-19 
Donabedian developed three analytical domains, which include structure, process and outcome 
attributes. The structure domain comprises the physical attributes of health facility, availability of 
equipment, stock outs, human resources and supervision, peer review, training and organizational 
structure. The process domain includes an assessment of the appropriateness and completeness of the 
physical examination and diagnostic tests applied as well as the clinic history taken, the evidence of 
preventive management of health conditions, and the continuity of care.20 Outcome attributes include 
the effects of the health care service delivery on patients and populations and may include elements 
such as patient satisfaction.15 
Patient Satisfaction 
Assessment tools that have examined the quality of care from the perspective of the client have also 
been developed as a means to ascertain patient satisfaction.21-24 Initially, a framework was developed to 
measure the quality of family planning services as perceived by respondents.21 This framework was later 
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adapted by Lule et al. in 200022, to appraise the quality of a broader spectrum of maternity services. The 
elements that went into the framework included the provider-patient relationship, the technical 
capacity of the providers including aspects of information exchange and the thoroughness of the 
examination, the women’s rating of the physical infrastructure of the facilities, the availability of 
services and supplies, and aspects of organizational management including working hours and waiting 
times.22 
Different theories exist as to how individuals attach importance values to different elements of care. It 
has been argued that if personal experiences have been negative with regards to certain aspects of 
health service delivery, then they are deemed more valuable. In contrast, however, some have argued 
that in countries with low variations in negative experiences, people’s expectations are generally low. 
This suggests that the institutional management of the health care system provides a mechanism 
through which individual value is attached to elements of service delivery.23 Studies have found that 
service users have ranked elements of the provider-patient relationship as well as service accessibility 
higher than other elements of the service such as waiting times.23,24 
Other studies assessing patient perception of care found that biomedical knowledge and the medical 
interventions provided were considered by patients as less indicative of the provider having a personal 
interest in the women in comparison to health care workers taking their time during the consultation 
and listening to their concerns. 24 Data from other studies have pointed to several factors that influence 
women’s decision to seek care. A study of Xhosa women in South Africa found that women needed to 
be assured of access to health care in labour.25 Evidence from India found that complicated or serious 
conditions, fear of condemnation by health care providers for failure to comply with treatment advice25, 
and satisfaction with care during previous visits were all associated with health seeking behaviour. 
26,27Other concerns that have arisen include provider-patient power dynamics where women feel that 
their knowledge is not respected while care provided has been described as ‘abusive, humiliating, 
uncaring and negligent’.28-31These perceptions have critical implications on the acceptance and use of 
services.32-34  
In an assessment of the perceptions of quality of care by women attending an antenatal facility in 
Malawi, women discussed concerns around the limited interaction time they had with providers as well 
as issues around privacy. There was some satisfaction amongst the women with regards to other aspects 
of the quality of care, however, the selectivity in satisfaction points to the potential impacts of 
expectations of care as a result of levels of knowledge obtained from health education and media 
sources. Experiences from the prior use of health services and perceptions of the health system were 
also thought to influence patient satisfaction. The authors noted that high variability amongst the 
responses of users of the service further highlighted that women pay attention to and are affected by 
the quality of care they receive.22 
The evaluation of health services 
Surveys have commonly been used to evaluate health services. The eight main facility-based assessment 
tools currently used at both national and programme levels worldwide include the Service Provision 
Assessment (SPA), Facility Audit of Service Quality (FASQ), Health Facility Census (HFC), Service 
Availability Mapping (SAM), Health Facility based survey of Human Resource for Health Services (HRHS), 
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Rapid Health Facility Assessment in Child Health (Rapid HFA), Access, Quality, and Use in Reproductive 
Health (ACQUIRE) Evaluation of LAPM Services (ELMS); and Population Council Health Facility 
Assessment (PCHFA).35 
The tools allow for the evaluation of a wide range of elements related to service provision so as to 
inform policy and planning from district to national level worldwide, in order to improve the delivery of 
care. Some tools have been developed to specifically target particular services, including the AQUIRE 
Evaluation of LAPM Services (ELMS) focusing on Family Planning/Long Acting and Permanent Methods 
(FP/LAPM) services, the Population Council HFA (PCHFA) focusing on reproductive health services and 
the R-HFA focusing on maternal newborn and child health services at the primary health care level. This 
R-HFA tool has been used for the piloting of interventions for service quality improvement in Africa and
Asia.35
Impact of quality of Antenatal Care 
Shortcomings in the delivery of high quality antenatal care have repercussions on maternal and child 
health and place an additional cost burden on the health care system. 36 Countdown was an MDG-
related initiative that was developed in 2005 to track coverage data on interventions addressing 
maternal, newborn and child health in 68 countries that account for approximately 95% of maternal and 
child mortality worldwide.37 The interventions and approaches that have been assessed by Countdown 
have had proven effectiveness for the reduction of mortality. Implementing evidence-based policies 
through investments in equipment, medical supplies and infrastructure are beginning to take place, 
although more is required for successful health systems development. Factors including shortages in the 
availability of human resources and the HIV burden have impeded the implementation of these 
interventions, and contributed to the slow progress towards reduction of mortality in women, newborn 
babies, and children. Only 22% of the countries have met the minimum threshold deemed necessary by 
the WHO to deliver essential health services.38,39  The availability of emergency obstetric care remains  
low with data on 20 of the Countdown countries reflecting an availability of less than 50% of the 
required facilities.1 
The ’Saving Mothers’ report highlights the need for support from government and non-governmental 
agencies and an accountability system in place to ensure the quality of health services.10 Provisions of 
the South African National Health Act of 2003 and the Policy for Quality set recommendations for 
performance and accountability. Some of the aims set by government outlined in the Policy for Quality 
Health Care to improve the standard of all health services delivered include: assessing issues of access, 
increasing patient participation, a focus on preventive and promotive activities, increasing research on 
operational effectiveness, ensuring appropriate use of health care services and reducing adverse events 
in the health care setting. The four main target areas of the interventions included health professionals, 
patients, the community and the health service delivery system.36Despite the recommendations, 
operations research in South Africa suggests that there are a number of factors that continue to impact 
on the quality of ANC services. Studies have focussed on elements of service management and delivery, 
including the training of health professionals; staff morale; patient waiting times; as well as the privacy 
of patient-provider interactions and comprehensiveness of consultations.  
In 2000, the National Primary Health Care Facility Survey found that only 87.4% of clinics provided 
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antenatal care, and the services were not provided daily.40 Subsequent to these findings, the National 
Health Act of 2003 stipulates that the delivery of all health services is the responsibility of the provincial 
health department and antenatal care should be routinely provided to low risk women at all primary 
health care facilities. Research has shown that many facilities still restrict visits to certain days of the 
week.41 Antenatal services rendered in the facilities should be recorded and reported so as to ensure 
adherence to guidelines, although a number of studies have found that this is not the case. 41-43 
Antenatal guidelines provide a means by which services and interventions that have proven positive 
impacts are translated into practice and the mechanism by which the gap between standards of care 
and actual practice can be measured. 
 An analysis of the services provided during antenatal care has highlighted the detection of particular 
risk factors and the implementation of specific interventions that have been shown to be effective in 
preventing maternal mortality and morbidity, including screening for anaemia, high blood pressure, 
infections and STDs and the provision of appropriate treatment. 44While the South African government 
has provided national antenatal guidelines that have been adapted to suit localized conditions in the 
individual provinces, there is no system in place to assess whether facilities are adhering to these 
guidelines.  An assessment of 141 public sector PHC facilities nationally found that the national 
guidelines could only be found in 46% of the facilities.45 
The PMTCT programme, by being integrated with antenatal services, ensures the provision of 
comprehensive health services. Data collected for 2008 have shown that approximately 50% of HIV-
infected women had access to PMTCT services in South Africa.47 Many studies assessing PMTCT 
programme coverage have documented attrition along each step of the PMTCT cascade.48 Reasons for 
non-acceptance of testing or prophylaxis vary across settings, but may be related to poor understanding 
amongst pregnant women, denial or fear of stigma.49 Other factors include service-related barriers to 
care. A study conducted to assess the operational effectiveness of PMTCT programmes across three 
districts in South Africa found the overall quality of a particular health service explained some of the 
differences in HIV transmission rates and mortality across the sites. Although utilisation of antenatal 
services was high, syphilis testing and the uptake of nevirapine was poor.50 Programme evaluations from 
a number of countries in Africa found failures at each point along the PMTCT cascade including uptake 
of antenatal testing51,52, receipt of test results, 53uptake of ARVs 54-56 and postnatal follow up.50In 2006-
2007, South African antenatal service coverage was 90%12 yet HIV testing rates were 69%57. Furthermore 
two other studies at the time showed that one third of HIV-infected women did not receive nevirapine 
at delivery, 10 although 84% of all births were assisted by trained health personnel.12 The integration of 
PMTCT programmes into health systems that are overburdened and under resourced may have 
contributed to the sub-optimal outcomes seen.58In order to minimize attrition along the PMTCT cascade, 
compassionate staff within well functioning antenatal, intrapartum and postpartum services with good 
laboratory support and referral services are required. In addition the services need to be well resourced 
and have a reliable source of tests and medications such as ARVs as well as a monitoring system to 
continuously evaluate outputs outcomes and impact.59  
Documented shortages and inequitable distributions of human resources in the Countdown Report led 
to recommendations for workforce management.  Capacity building initiatives included the need for 
investments in the education and training of health care workers, in addition to task shifting. 
Furthermore, strategies to keep personnel motivated so as to enhance staff retention were also 
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required.1 The lack of privacy at many facilities and the fact that patients often see a number of different 
providers during their visit adversely impacts on good communication and the fostering of a good client-
provider relationship. Consequently many women find it difficult to discuss personal problems and 
concerns.60A study conducted in Kwazulu Natal found that in spite of arriving early for their antenatal 
appointments and spending many hours at the facility, women spend on average 4.5 hours in the 
facility, 4 of which is spent waiting to see a provider.41 In a study undertaken to explore service 
providers’ perspectives on challenges in the work place in the Western Cape, several quality concerns 
arose related to the provider-patient relationship. The most notable theme that emerged related to 
nurses’ abuse of patients.  Patients reported having been victims of verbal abuse, felt that their 
autonomy was not respected and described acts of unkindness, violence and neglect by health 
providers.61 In another study on quality of care at contraceptive services, 20% of women reported that 
the provider scolded them. 62 These concerns are indicative of organisational challenges and a lack of a 
system of accountability, workplace concerns amongst nurses and uneven power dynamics between 
users and health care personnel.61
Low morale amongst health care providers may explain some of the dynamics seen during patient 
consultations. A nursing dynamics study found that 27% of nurses reported that they did not care for 
patients like they used to while 60% felt a lack of motivation to work as hard. 63 The nurses attributed 
the low level of motivation to limited opportunities for promotions, poor management as well as staff 
shortages. 63 A five year review of the public sector carried out in 1999 also found that the morale 
amongst staff was very low, especially among nurses. Although the nurses attributed low morale to 
being overworked, feelings of neglect and lack of support is also believed to have contributed.64 It is 
thought that the morale of health workers will improve by fostering a sense of purpose and personal 
fulfilment; this could be facilitated through the articulation of a clear vision and plan by national and 
provincial managers.65 
Beyond the economic, logistic and provider related challenges to access to antenatal and emergency 
obstetric care, a lack of awareness amongst women of the danger signs for complications during 
pregnancy and delivery is related to delays in health seeking behaviour.66-73 The Safe Motherhood 
Initiative recommends the provision of education around pregnancy related complications and access to 
seek care. Antenatal visits provide the opportunity for the delivery of health education. In a 2009 study 
by Nikiema et al.74, 15 of 19 sub-Saharan African countries including South Africa reported that health 
information was not routinely provided to over 50% women at antenatal visits.74 Furthermore, it was 
speculated that such study findings extend beyond these 19 countries and represent a widespread 
challenge to providing reproductive health information in Africa. 69, 71 
Areas for future Research 
Despite the availability of a wide range of measurement tools, few evaluations of antenatal care services 
have been conducted in South Africa.  A national HIV prevalence population survey from 2008 
conducted by the Human Sciences Resource Council found that 97% of women had access to antenatal 
care while pregnant with approximately 71% attending at least five antenatal visits. In addition, the 
study found that the majority of pregnant women were attended by a skilled birth attendant during 
labour. 75 Despite this, maternal mortality remains high according to the Saving Mothers Report, which 
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suggests that challenges to delivering high quality care still persist and that the quality of ANC services 
needs further evaluation10.  
Antenatal care provides the opportunity for the early detection of high-risk pregnancies as a means of 
reducing maternal mortality. 76, 77 The provision of free maternal care in public health facilities in South 
Africa is an integral step towards improving access to essential health services, although the provision of 
quality care must be ensured. Costs saving calculations have shown that for every dollar spent on 
antenatal care on high-risk women, over 3 dollars are saved on the management of complications 
arising during pregnancy.78 Furthermore, the provision of PMTCT and ARVs for HIV positive pregnant 
mothers is an important reason to seek out antenatal care. 
In order to gain insight into factors associated with patient satisfaction and the values service users 
attach to different elements of care, better understanding of  the mechanisms through which 
performance and importance ratings are associated is required. This may in turn include a comparison of 
individual experiences with other users as well as an analysis of the institutional makeup of the health 
system in South Africa. 
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Abstract 
Background 
Investigations into maternal and child deaths in South Africa and assessments of PMTCT programs have 
found poor quality of perinatal care in district hospitals. A substantial portion of perinatal deaths have 
been attributed to avoidable health system failures. Despite this, many studies have reported that 
women are satisfied with the quality of antenatal care (ANC). A facility survey of ANC services in two 
South African provinces evaluated adherence to antenatal guidelines, levels of patient satisfaction and 
linkages between perceptions of quality, the structural and organizational attributes of ANC services, 
and the care delivered by health providers. 
Methods 
This cross sectional facility survey included clinical observations, structured provider interviews and 
patient exit interviews to assess the quality of health services as well as patient perceptions in the 
Western Cape and Free State provinces. Regression analysis was conducted to determine whether there 
were significant predictors of patient satisfaction.  
Results 
The assessment showed high overall quality of care delivered in both provinces and a high level of 
adherence to standard operating protocol. Women attending facilities in the Free State had higher 
levels of satisfaction, with a score of 88% compared to 76% in the Western Cape on a 100% satisfaction 
scale, with no overlap between the confidence intervals of the scores. The regression analysis did not 
demonstrate any factors significantly associated with patient satisfaction.  
Conclusion 
There was a high level of adherence to protocols indicating good quality of care in both provinces. 
Health facility and patient satisfaction assessments provide useful insight into the quality of patient care. 
However, it is difficult to determine whether patient satisfaction correlates with good quality of care, 
despite some indication in this study of a trend towards increased satisfaction with the provision of 
services. Satisfaction may be dependent on predetermined expectations rather than the actual quality 
of care received. Ongoing assessment of the quality of health services is essential for health systems 




Global evidence suggests that there has been uneven progress towards attaining the targets of the 5th 
United Nations Millennium Development Goal to reduce maternal mortality and improve universal 
access to reproductive health care by 2015. Challenges remain due to limitations in the provision of 
maternity services, barriers to accessing emergency obstetric care, and the education of women around 
maternal health.1 Maternal and child health is further challenged as a result of the HIV epidemic. 
According to UNAIDS, approximately 370 000 children were infected with HIV in 2007, 90% of infections  
being due to vertical transmission from mother- to- child (MTCT), with  the majority  of these infections 
occurring in Sub Saharan Africa. 2 Over one third of childhood deaths were caused by HIV in high 
prevalence countries including South Africa in 2007,3 severely threatening the gains made in child 
survival.  
In South Africa, despite near universal ANC uptake and access to obstetric care, HIV has been found to 
impact considerably on maternal mortality, which remains high according to the Report on Confidential 
Enquiries into Maternal Deaths (The ‘Saving Mothers’ Report, 2005-2007).4 A national HIV sero-
prevalence population survey in 2008 found that 97% of women had accessed antenatal care with 71.4% 
attending at least five antenatal visits. In addition, the study found that the majority of deliveries were 
attended to by a skilled birth attendant. 5  According to the  Saving Mothers Report  among mothers who 
died during or within 6 weeks of pregnancy and had been tested for HIV,  79% tested  HIV-positive 4. This 
suggests that challenges to delivering high quality care still subsist and that the quality of ANC services is 
poor.  
The ‘Saving Mothers’ Report, approximates that  almost 60% of maternal deaths in South Africa  were 
avoidable and over half of these deaths were attributed to health systems failures. 4 In addition, the 
‘Saving Babies’ report for 2006-2007 found that the quality of perinatal care in district hospitals was 
poor, and over one third of perinatal deaths were due to avoidable health system failures.6The ‘Saving 
Mothers’ report attributed failures to a lack of health care facilities, poor transport to or between 
facilities, a lack of appropriately trained staff, non-adherence to standard operating procedures, poorly 
conducted initial assessment of patients and poor problem recognition. 4  
The Guidelines for Maternity Care in South Africa,7 outline the essential elements of antenatal care. 
Basic Antenatal Care (BANC) offered at primary health care clinics includes monitoring for and treating 
pregnancy-related complications, providing micronutrient supplements, and counselling on preventive 
care and treating sexually transmitted infections (STIs). Education on the process of pregnancy and 
childbirth, the recognition of complications; and appropriate health behaviour, including nutrition, 
personal hygiene, exercise and feeding options should be conducted.  Women should also be 
encouraged to test for HIV and other sexually transmitted. Prevention of mother-to-child transmission 
of HIV (PMTCT) program are integrated with antenatal services, and ensure  the provision of counselling 
and testing and antiretroviral (ARV) therapy to HIV positive women in pregnancy.  
Little is known about the effectiveness of antenatal care in preventing maternal mortality 8 A review by 
Carolli et al.8 on the outcomes of antenatal services in developing countries has highlighted the 
detection of particular risk factors and the implementation of specific interventions that have been 
shown to be effective in preventing maternal mortality and morbidity. These interventions have 
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included screening for anaemia, high blood pressure, infections and STDs and the provision of 
appropriate treatment by trained staff. 8 In addition, improvements in the coverage of ANC services, the 
education of women and quality of care have been linked with a decline in maternal mortality and 
improved MDG 5 indicators.9
Despite the evidence suggesting concerns around quality of care, research has shown that women are 
generally satisfied with the quality of care in South Africa.  An assessment of reproductive health 
services in Kwazulu-Natal found clients reporting that they were satisfied with services. The study 
suggested that clients received the services and information they sought and would even encourage 
others to attend .10 Despite a high level of overall satisfaction, clients made note of long waiting times 
and being turned away from services as a result of overcrowding and limited hours. Positive responses 
with regards to client satisfaction with services are often believed to be influenced by low expectations 
amongst users of the services, or social desirability bias.10 
As referred to above, research into the quality of care can be conceptualized from the point of view of 
service users, as perceived quality, or by objective technical standards defined by professionals in the 
field.  Objective standards may either focus on the care delivered to patients or on their health 
outcomes. The first approach concerns whether medical practices that have proven positive outcomes 
have been applied, while the latter concerns maternal and child morbidity and mortality. 11 A framework 
for analysis is drawn from Donabedian, who developed the principle of quality in health care and 
operationalized quality evaluation in health service settings.12This approach has  been widely adopted in 
other developing contexts.13-16 Donabedian developed three analytical domains for assessing quality, 
including structure, process and outcome attributes. The structure domain includes the physical 
attributes of health facility, availability of equipment, stock outs, human resources and supervision, peer 
review, training and organizational structure. The process domain includes the health care worker 
conduct and competence. The process evaluation will include an assessment of the appropriateness and 
completeness of the physical examination and diagnostic tests applied as well as the clinic history taken, 
the evidence of preventive management of health conditions, and the continuity of care. Outcome 
attributes include the effects of the health care service delivery on patients and populations and may 
include elements such as patient satisfaction.  
In light of the documented lack of quality of antenatal care observed in developing country settings, 
although not always supported by the perceptions of users of the services, and its implications on 
maternal and child mortality, the study aims to describe and compare antenatal service delivery in two 
provinces in South Africa. It also aims to assess patient satisfaction regarding the quality of antenatal 
care using Donabedian’s analytical framework.12 
Methods 
Study setting and sampling 
This study was part of a larger study to determine the effectiveness of PMTCT programmes in 4 African 
countries (The PEARL Study).17 In South Africa, the Western Cape and Free State provinces were selected 
because the researchers had access to facilities in these provinces. These provinces were also different 
in terms of socio-demographic make-up and resources available.  The sampling frame for the facility 
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survey consisted of the antenatal clinics that referred patients to the delivery sites where cord blood 
surveillance had taken place, the first component of the PEARL study.17 A non random sampling 
technique was applied in order to ensure that the clinics with the largest number of attendees in the 
three randomly selected sub-districts in each province were chosen.  Selected sites in the Western Cape 
included two midwife obstetric units (MOUs) which offered both ANC and delivery services, and three 
BANC sites which offered ANC only, with referral on to a local hospital, while 13 sites in the Free State 
were selected A convenience sample of 6 consecutive women attending the service was selected for exit 
interviews.  In addition, field workers observed consultations with six women other than those who 
participated in the exit interviews. An interview was also conducted with the health care provider in 
charge of the antenatal service on the day of the survey. Informed consent was obtained from both the 
pregnant women and the providers. Data were collected between October 2008 and May 2009. All data 
were entered electronically into a Microsoft Access database. Data were cleaned in Access through cross 
checking a 10% sample of electronic entries against the hard copy version. Consistency checks were run 
to ensure accuracy of the data entered. The database was imported to STATA statistical software ( Stata 
Corporation, College Station, Texas)  for analysis. 
Operational definition of quality of care, data collection and analysis 
The facility survey was divided into 4 modules.  The first module constituted the direct observation of 
the quality of clinical care of a consultation. The second was an exit interview with women attending the 
facility, in order to measure perceptions and knowledge of care.  The third was a health facility 
assessment using a checklist to document infrastructure, equipment and drugs. Finally an interview with 
the health facility manager regarding services provided at the health facility and the human resources 
involved in the services was conducted. All components of the survey were conducted by clinically 
trained field workers. Exit interviews with patients were carried out in the patient’s mother tongue, 
while health care provider interviews were carried out in English or isiXhosa, Afrikaans, or SeSotho. 
This study analysed the quality of care from service and patient perspective based on a framework 
developed by Donabedian.12 The facility survey content was divided into three analytical domains, 
defined by the investigators as structure, process and outcome attributes (See Table 1-for elements 
included in survey) 
Descriptive statistics for both provinces were compared using point and confidence interval estimates of 
the prevalence of facility attributes and activities conducted.  Median scores and interquartile ranges 
were used as the data was non- parametric. Confidence Intervals were used to reflect the uncertainty in 
the estimates due to the small sample sizes of the facility survey. While the degree of overlap of the 
confidence intervals served to compare the facilities, it is important to note that this approach suffers 
from the lack of power associated with the wide confidence intervals due to the small sample sizes. 
Variables that were patient specific within the process domain, such as tests performed on the 
individual women during the consultation, were aggregated by facility and proportions were used to 
compare the provinces.  
The primary element analysed for Donabedian’s outcome domain was patient satisfaction. Patient 
satisfaction was measured from an average score for each facility from a number of different Likert 
items. The patient scores were derived from the exit interviews in which the women attending the 
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facilities were asked to respond to how they felt about a series of statements concerning the care they 
received on the day the survey was conducted. Responses were scored using a Likert scale of 1-5 ranging 
from ‘strongly disagree’ to’ strongly agree’. In order to derive a patient satisfaction score, scores 
obtained on each of the 16 questions were added up, and averaged across the 6 women from each 
facility to get an average satisfaction score for each site. The ordering for the positively loaded 
statements was reversed relative to the negative ones, so that a higher score reflected a higher level of 
satisfaction. Differences in the median scores between statements pertaining to patient satisfaction 
were compared using the Rank-Sum test, a non-parametric test for independent samples. 
In order to identify relationships between predictor variables and the outcome, multiple linear 
regression was used. The design effect was accounted for in the regression analysis through the use of 
the survey command by stratifying by province; the primary sampling unit was the individual facility. 
Variables selected to be included in the regression analysis were either based on a significant difference 
in their values across the provinces or elements that were highlighted in the literature as influential 
contributors to quality of antenatal care and patient satisfaction.  
Results 
Structure 
Table 2 reflects the structural attributes of the facilities in the two provinces. All of the sites in the Free 
State had HIV testing kits available and provided both visual and auditory privacy during the 
consultation. Furthermore, 100% of the sites in the Free State had both maternal nevirapine and AZT 
available. In the Western Cape, 100% of the facilities had maternal AZT available and provided HIV 
testing within the ANC building. In order to compare the Provinces with regards to the structural 
attributes of their facilities, the degree of overlap between the confidence intervals of the variable 
responses was analyzed. Provinces were comparable with respect to the location of HIV testing, soap 
availability and the availability of maternal AZT as can be seen from the large degree of overlap in the 
confidence intervals. Differences between the provinces were reflected in the quality of the location 
women are seen for privacy, the availability of nevirapine and the availability of HIV testing kits, 
although the latter to a lesser degree. 
Table 3 reflects the distribution of health care workers in the two provinces. Both the Western Cape and 
the Free State had a median of 4 nurses trained in HIV testing per site. Since it was reported that a 
median of 11 nurses and midwives were hired across the facilities in the Western Cape, this reflected an 
overall 36% of mid-level providers trained in HIV testing for the Western Cape. There was a median of 7 
nurses and midwives hired in the Free State, indicating that 57% of mid-level providers were trained in 
HIV testing in the Free State. In the Western Cape a median of 1 nurse was trained in PMTCT dispensing 
per site, while in the Free State a median of 3 nurses were trained. This indicates that 9% of mid-level 
providers in the Western Cape and 43% of providers in the Free State trained in PMTCT dispensing.  The 
provinces were different with respect to the number of midwives hired, with no overlap between the 
interquartile ranges of the two provinces, although comparable with respect to the number of nurses 
hired. This could be as a result of the numbers of women using the services, although such data is not 
reported here. The provinces were also comparable in terms of the number of nurses/midwives trained 
in HIV testing, reflected in the large degree of overlap between the interquartile ranges but different 
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with respect to the numbers of nurses/midwives trained in PMTCT dispensing. 
Table 4 reflects the organizational structure of the two provinces.  In the Free State more than 90% of 
the facilities reported there was pre/in-service training within the past 3 years, technical support within 
the past 4-6 months, training on topics such as prophylactic drugs to pregnant women and 
breastfeeding, the availability of guidelines on select topics, and husbands/partners being offered HIV 
testing. However comprehensive training on all of the topics was low in the Free State, with 15% of sites 
offering training on all of the topics. In the Western Cape between 80 and 100% of facilities reported 
pre- service training, technical support, training in rapid HIV testing, prophylactic  drugs to pregnant 
women, breastfeeding and newborn care, the availability of guidelines on select topics, 
husbands/partners being offered testing and availability of HIV support groups to women in their 
communities. The facility survey also assessed the provision of ART to pregnant women in the facility as 
a means of ascertaining the integration of PMTCT services within antenatal care. Approximately 46% of 
the facilities in the Free State and 60% of the facilities in the Western Cape were offering ART to 
pregnant women.  
Comparing the degree of overlap in the confidence intervals from table 4, it was shown that the 
provinces were different with respect to attributes including the training on all of the topics covering 
prophylactic drugs to pregnant women, breastfeeding and newborn care, the availability of guidelines 
on immunisation, the offering of HIV testing to partners, and the availability of HIV support groups. A 
higher proportion of the Free State facilities provided training on prophylactic drugs to pregnant women 
and breastfeeding, as well as HV testing services to partners/husbands, while a higher proportion of the 
Western Cape facilities provided the remaining above mentioned services . Most strikingly, almost 
double the number of the facilities in the Western Cape provided HIV support groups in the 
communities in comparison to the Free State. The provinces were comparable on all of the other 
organisational attributes as reflected from the large degree of overlap between the confidence intervals. 
Process 
Table 5 describes elements of the provider-patient interaction at the antenatal facilities. All women in 
both the Western Cape and Free State were examined by nurses. The educational talks included topics 
such as HIV, nutrition, good antenatal care, safe delivery, breastfeeding, family planning, and PMTCT. 
The BANC sites, reflecting 3 of the 5 sites included in the study in the Western Cape were the ones 
which gave educational talks. Breastfeeding and PMTCT were covered at all sites, while antenatal care, 
safe delivery and family planning were not covered on the day the survey was conducted in the Western 
Cape across all the facilities. There was much more variability in the Free State concerning the topics 
covered for educational talks, with HIV being covered the most consistently in the sites. The provinces 
were different with respect to the provision of health education covering topics including HIV, Good 
Antenatal Care, and Safe Delivery, but comparable on all other topics, reflected in the degree of overlap 
of the interquartile ranges. 
In the Free State, CD4 results were received within 7 days whereas the Western Cape took between 7-
14 days to report back results. All of the sites in the Western Cape only provided nevirapine at delivery, 
while most of the sites in the Free State provided nevirapine most commonly from 28 weeks gestation 
and some between 30-36 weeks gestation.  The differences between the provinces were further 
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reflected in the limited degree of overlap between the interquartile ranges of the responses, with no 
overlap at all for the response pertaining to the provision of nevirapine. 
The patient specific elements listed in Table 5 were transformed to reflect facility specific elements by 
averaging the patient responses for each facility. All of the activities for both the Free State and Western 
Cape had a median of 100% with the exception of providing ferrous sulphate to patients. There was a 
substantial difference in the range of responses across the facilities in the Western Cape in comparison 
to the Free State. The monitoring of the foetal heart conducted during the patient visits in the Western 
Cape had the largest interquartile range, which varied between 33% to 100% of the facilities, while 
several of the other variables, including taking the patient’s blood pressure and palpating them had 
much less variability, ranging from approximately 83% to 100% of the facilities. Ferrous sulphate was 
provided at 33% of sites in the Free State while it was provided at 66% of the sites in the Western Cape  
All patients tested for HIV were informed of their result on the same day. The only exception to this was 
patients from a site in the Free State that did not provide rapid tests for HIV. All of the women in the 
Western Cape and 95% of the women in the Free State who tested positive, had their blood drawn for a 
CD4 test. Over 87% of women in the Free State and 90% in the Western Cape who presented for the first 
time at ANC had blood drawn for a syphilis and haemoglobin test.  
Outcome 
Table 6 summarizes patient levels of agreement on a series of statements relating to their levels of 
satisfaction with different elements of the ANC facilities attended and care received. Table 6a 
summarizes patient responses to positively worded statements; where a high score indicates agreement 
and hence high levels of satisfaction. Table 6b summarizes patient responses to negatively worded 
statements and here a high score indicates disagreement with the statement, and hence satisfaction. 
Over 90% of the women in the Free State and the Western Cape were highly satisfied with the service 
provided, although women in the Free State had higher levels of satisfaction.  There was less satisfaction 
in terms of the health facility having everything required for complete care. There was some 
dissatisfaction with respect to the amount of time patients felt the doctors and nurses spent with them, 
with only 90% in the Free State and less than 80%of women in the Western Cape feeling that the health 
care worker had spent enough time with them. Approximately 15% of women in the Free State and 27% 
of women in the Western Cape felt that the doctors and nurses hurried through care. There was some 
dissatisfaction with patients feeling that the health care workers ignored what they said, especially in 
the Western Cape, in addition to large proportions of the women in the Free State and Western Cape 
who were either unsure or agreed with the statement that the doctors and nurses were rude and 
impersonal. Approximately 13% of women in the Free State had doubts about the abilities of the 
doctors and nurses, while a larger proportion of women in the Western Cape were unsure (17%). 
Approximately 50% of women in the Western Cape agreed with the statement that they were unsure if 
the information they received during their visit was correct, while another 33% were uncertain A little 
over 20% of women in the Free State and the Western Cape agreed that they were dissatisfied with 
some aspects of care they received. The median scores between the Free State and Western Cape for 
the series of statements provided to the women, except those concerning the time spent with the 
patient and dissatisfaction about some aspects of care, were significantly different(P<0.05), with the 
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median score in the Free State consistently higher. 
Women attending facilities in the Free State had on average higher levels of satisfaction, but satisfaction 
was generally high (>75%) in all of the facilities. In the Free State the average level of satisfaction was 
88%, while in the Western Cape, the average level of satisfaction was76%, with no overlap between the 
confidence intervals of the scores between the provinces.  
All patients in the Free State had a correct understanding for the reason they were prescribed their 
medication as well as the dosing requirements, while approximately 72% of the patients in the Western 
Cape had a correct understanding of their medication requirements. As there was no overlap in the 
confidence intervals, patient comprehension was significantly different between the provinces. 
Table 7 presents the results from the regression analysis relating patient satisfaction to the structural 
and process attributes of the antenatal facilities in the two provinces.  
No variables were significantly associated with patient satisfaction in the regression analysis. Despite 
this, the confidence intervals for all the variables were positively skewed, with the exception of the 
length of time to receive CD4 results, suggesting a positive association with patient satisfaction . When 
guidelines were observed, patient satisfaction went up by 8.75 percentage points. When the provider 
listened for the fetal heart tone, patient satisfaction went up by 17.16 percentage points. When there 
was both auditory and visual privacy, patient satisfaction went up by 20.67 percentage points. When the 
health care workers were trained within the last 3 years, patient satisfaction went up by 4.25 
percentage points. CD4 results had a negative association with patient satisfaction; where when it took 
longer for patients to get their CD4 results, patient satisfaction went down by 5% percentage points. 
Discussion 
The facility survey showed that the quality of antenatal care was generally high in both Provinces with 
strong adherence to antenatal and PMTCT guidelines as reflected in the responses of the variables 
previously categorized according to Donabedian’s structural and process attributes.12 
Similar to other studies that have demonstrated attrition along the PMTCT cascade18 the facility survey 
shows that not all of the women received the required care which includes voluntary HIV counselling 
and testing during antenatal visits, and the delivery of antiretroviral therapy to HIV-infected pregnant 
women. Over 10% of the women attending facilities in the Free State for their first antenatal visits did 
not get tested, while 5% of women in the Western Cape were not tested. All of the sites in the Western 
Cape and 84% in the Free State conducted HIV testing at the ANC site. Privacy during the counselling 
session in the Western Cape was a problem with sites lacking auditory privacy.    The lack of privacy at 
many facilities and the fact that patients often saw a number of different providers during their visit 
adversely impacts on good communication and the fostering of a good client-provider relationship. 
Consequently many women find it difficult to discuss personal problems and concerns.19 
As the majority of the sites conducted rapid HIV tests, all the women received their results on the same 
day. This is highly effective, as losses to follow up occur often when women have to come back at a later 
date for their blood results, including HIV and CD4 testing. The high levels of testing reflect the 
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successful integration of PMTCT programs into antenatal care.  Testing for syphilis and haemoglobin 
were also relatively good, with over 90% of the women in both the Western Cape and the Free State 
being tested.   
Furthermore, studies have demonstrated that the provision of a single-dose nevirapine regimen at the 
onset of labor is an easy and affordable intervention to reduce the vertical transmission of HIV.  Many 
women commence labour a long time before arriving at a delivery facility and thus many services 
provide nevirapine to women from 28 weeks gestation so that they can take it as soon as labour 
commences.  In the Western Cape, women were only provided with nevirapine at the facilities during 
labour, but in the Free State, 11 of the 13 facilities provided women with nevirapine to take home with 
them. As a result, all of the facilities in the Free State had nevirapine available on location, while only the 
facilities in the Western Cape that had labour wards, had nevirapine available. 20,21 
The rapidly evolving health sector and technological innovations pose a great challenge to health 
professionals. Advances in the screening, prevention and treatment of diseases make it essential for 
health care workers to keep up to date with training.22  Furthermore, the large volume of information 
available often feels daunting for health professionals.  The 2007 National Policy on Quality in Health 
Care 20 recognizes the important role that the ongoing training of skilled health care workers plays in 
promoting the provision of high quality, evidence-based health care practices.  This can be facilitated by 
making clinical literature and guidelines available to health care workers. These best practice guidelines 
can be adapted in local contexts and help facilitate the provision of care. Furthermore, the policy22 
recognizes that the training of health care workers will require a focus on quality improvement skills 
supported through mentorship and supervision.   
The majority of the facilities in both provinces had guidelines covering topics including immunisation, 
antenatal care and PMTCT available.  All of the sites in the Western Cape, while over 90% of the sites in 
the Free State received pre-service training related to maternal, child and newborn health in the past 3 
years. All the sites in both provinces received technical support and supervision in the past 6 months.   A 
low number of mid-level providers in both the Free State and Western Cape were trained in HIV testing.  
With respect to training in PMTCT dispensing, even fewer mid-level providers were trained.  Facilities in 
the Free State provided training to more of their mid-level providers than the Western Cape did, but this 
could be partly attributed to most of the facilities in the Western Cape having hired more midwives. 
Refresher training on selected topics was much more variable in the Provinces.  In the Free State over 
75% of the facilities had received training within the past 3 years in rapid HIV testing, breastfeeding and 
prophylactic drugs to pregnant women. Training in newborn care was much less frequent with 
approximately 15% of the sites having received training.  Training in the Western Cape was better with 
no less than 80% of the sites having received training on the above mentioned topics.  
There is an increasing recognition of the importance of male involvement in the reproductive health 
issues of their partners.23 Many men do not accompany their partners to family planning, antenatal and 
postnatal services.23 Research has highlighted that women want their partners to become more involved 
in such decision making.24Furthermore, men are becoming more aware of the integral role they play in 
reproductive health decisions and would like to become more involved. Over 90% of the facilities in the 
Free State offered HIV testing to the husbands/partners of the pregnant women as part of the program, 
while in the Western Cape, 80% of the facilities offered the service, which highlights an important move 
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towards the greater involvement of men in antenatal  services, and more specifically sexual and 
reproductive health. The involvement of men in decision making around pregnancy and reproductive 
health issues is associated with health benefits for their children and families. The involvement of men 
may help modify risk behaviours and the uptake of antenatal services  It has become widely recognized 
that pregnancy in South Africa faces high risk when men, both as partners and decision makers, are not 
informed about the reproductive health issues of their partners and their own health.  The involvement 
of men may help modify risk behaviours and the uptake of antenatal and PMTCT services.25  
Community involvement has also been recognized as an integral to fostering a link between primary 
health care services and the users26-28, in addition to improving service quality. 29-31. While there is a 
dearth of evidence on the effectiveness of community participation  32,33 some studies have 
demonstrated that community groups for pregnant women have had an effect on reducing neonatal 
mortality rates, reducing maternal depression and improving decision-making.34,35 All of the sites in the 
Western Cape were noted to have HIV support groups in the communities that the facilities served, 
while only about half of the sites in the Free State had support groups in the communities.  
The provision of educational talks on the range of recommended topics was found to be poor. The 
topics covered the most consistently in the Western Cape were breastfeeding and PMTCT, while in the 
Free State, HIV was covered the most consistently, reflecting 62% of the sites. In the Western Cape, the 
BANC sites provided educational talks, and as a result, only 3 of the 5 surveyed sites were expected to 
do so. Furthermore, caution must be taken with the generalisation of these results as the questionnaire 
was only able to capture the provision of educational talks on the day of the survey, hence the talks may 
have not have been observed at other sites. The provision of educational talks is expected to take place 
during group counselling sessions; however, it is possible that further counselling occurs during the 
private individual consultations.   
Facilities in both provinces performed well with respect to taking patients’ blood pressure, palpating 
them, listening for a fetal heart tone and conducting a urine dip stick, with those tests conducted on 
almost all of the patients. Variability existed with respect to listening for a fetal heart tone, however. 
The provision of iron supplementation varied between the provinces, however, this may be due to 
extraneous factors including the eligibility of the women participating. However, the questionnaire did 
not allow for patients to be categorized according to their haemoglobin status, and there is a lack of 
consensus as to whether ferrous sulphate should be prescribed to non-anaemic pregnant women. 36,37 . 
Furthermore, issues have been raised concerning the possibility of adverse effects such as oxidative 
damage arising following the administration of iron supplements.38 
Different theories exist as to how individuals attach importance values to different elements of care. It 
has been argued that if personal experiences have been negative with regards to certain aspects of 
health service delivery, then they are deemed more valuable. In contrast however, some have argued 
that in countries with low variations in negative experiences, people’s expectations are generally low. 
39The facility survey reflects a high level of satisfaction by users of the services in both provinces, with an 
(overall) 87.8% satisfaction level in the Free State and a 76% satisfaction level in the Western Cape. 
Satisfaction levels related to the different elements of care were often higher for the Free State than 
they were for the Western Cape. This trend supports theories that expectation levels are poorer in lower 
resourced areas, and hence satisfaction with the provision of care will be higher. The statements 
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addressing patient satisfaction centred on some common themes which included the perception of the 
quality of care received, the time spent with providers and the availability of care, the quality of the 
patient-provider interaction, the medical knowledge received from providers, as well as the financial 
and physical accessibility of care. The antenatal services are free, and that is reflected in the responses 
by the women in both provinces in which they feel they feel that financial restrictions to accessing care 
do not apply. Patients felt more strongly about the explanations provided for their antenatal visits and 
the quality of the medical care received in the Free State in comparison to the Western Cape, while 
more women in the Western Cape had doubts about some of the information they received. Women in 
the Free State also felt that the checkups were more thorough and the time spent with them by the 
health providers was much more adequate as compared to women in the Western Cape. Variability in 
responses in both provinces existed with regards to the health facility being equipped to provide 
through care. These findings highlight that the interpersonal nature of the provider-patient relationship 
is deemed more valuable to patients as compared to the structural attributes of the health facilities, and 
dictate perceptions of quality.  
While the regression analysis did not point to any significant associations between the structural of the 
facility and the process elements of the provider-patient consultation, some trends were observed. The 
observance of guidelines and having trained health care workers increased the levels of satisfaction 
amongst women as did the quality of the location women had their consultations and whether providers 
listened for a fetal heart tone. The length of time it took for women to receive their CD4 results were 
inversely related to their levels of satisfaction. These study findings, while not significant point to trends 
which agree with what would be expected. The lack of significance in the study findings can be partly 
attributed to the very small sample size used for the facility survey. Furthermore, although all patients in 
the Free State understood their medication requirements correctly, while approximately 72% of patients 
in the Western Cape did, it is possible that this is dependent on the number of drugs that the women 
are prescribed; it is therefore important that levels of comprehension and accuracy of information is not 
solely attributed to the quality of the explanations provider by health care personnel.  
Generalizing the survey’s findings must be viewed in light of some of the limitations of the study. The 
study included 5 sites in the Western Cape and 13 sites in the Free State.  As stated earlier, the clinics 
with the largest number of attendees were those sampled for the survey. While this approach aimed to 
obtain a random sample from a large pool of women while eliminating the need to sample each clinic in 
the two provinces, some important elements of antenatal care in other facilities may have been missed. 
Furthermore, the women were selected for the study consecutively. This sampling technique adequately 
represents the population from which the sample was derived when a large enough sample size is 
selected. This was attempted by selecting 6 women for the clinic consultation and 6 different women for 
the exit interview; although the sample size for the study was still relatively small. In addition to 
describing the quality of care in the antenatal facilities studied, the survey attempted to determine what 
elements of care influenced patient satisfaction. The small sample size may have influenced the strength 
of the associations found in the regression analysis as none of the variables evaluated were significantly 
associated with patient satisfaction, although trends were observed. Elements that were captured by 
the survey included structural and organizational elements of the facilities as well as the process of the 
clinical examination. Other elements that have been thought to influence patient satisfaction that were 
not captured by the facility survey included the socio-economic conditions of the women including their 
educational status, income, amongst other factors.  
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Furthermore, the survey was adapted in order to be carried out in 4 countries in Africa, and as a result, 
some country specific conditions may have been overlooked in an attempt to cover elements of 
antenatal care that were common across all settings. In addition, the survey was cross-sectional in 
nature and documented the provision of care in the facilities during a single clinic observation. As a 
result, some variables including the number of health care personnel working during the particular day 
may not be stable across the working days. The survey attempted to control for the time dependent 
nature of some of the variables by asking about clinic practices such as the provision of training to staff 
and drug availability and stock outs for a period of 6 months preceding the day the survey was 
conducted. Lastly, it is important to recognize the possibility of social desirability bias by the women 
being interviewed and the conduct of the health care providers being interviewed The potential for 
women to provide positive feedback concerning their satisfaction with care, regardless of the quality of 
health care services provided, may have biased the study’s findings; this has been seen in other 
studies.14 The survey attempted to minimize this by asking the participants to respond to  statements 
that alluded to similar elements of care received, such as references to having received a thorough 
check up and having the health care provider spend sufficient time with the patient. Furthermore, the 
influence of direct observation on the health care provider’s practice was mitigated by the fact that the 
field workers were clinically trained, introduced themselves as such and were as discrete and 
unobstructive as possible; however, the Hawthorne effect remains a limitation on studies involving 
direct observation.  
Conclusion 
Concerns about the quality of health care and the performance of service providers has led to the 
development of strategies for the measurement of quality and improvement in health care provider 
performance as well as the promotion of best health care practices. Strategies include the supervision 
and regulation of medical practice, the development of national guidelines and standards, and the use 
of information systems.40 National leadership has been recognized as integral to the response to 
concerns about the quality of health care and stems from the influence of government, doctor’s groups 
and the private sector on the health care system. Furthermore, it has been recognized that professional 
performance improvement can be facilitated through the creation of evidence-based guidelines and 
standards to guide clinical care. Such tools serve as a means to assess the quality of clinical practice. 
What many countries are challenged with is the creation of acceptable standards of measurement to 
assess the performance of health care workers.40 Concerns with the methodology used to assess health 
care worker performance include inadequate risk adjustment strategies and difficulties in teasing out 
individual performance when several health care workers are involved in a patient’s care. 41 A point of 
contention lies in the extent to which performance related information should be made public in light of 
pressures towards increased levels of accountability. It is felt that such information has to be interpreted 
with caution with appropriate consideration of contextual factors and risk adjustment. 40 
In light of increased demands on health care workers, poor quality of care is often affected by low levels 
of morale. This study did not focus on staff morale, however, other studies in the setting have 
highlighted the impact of poor staff morale on quality of care. Low levels of motivation have been 
attributed to limited opportunities for promotions, poor management as well as staff shortages. 42in 
addition to feelings of neglect and lack of support.43 It is thought that the morale of health workers will 
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improve by fostering a sense of purpose and personal fulfilment; this could be facilitated through the 
articulation of a clear vision and plan by national and provincial managers.43  
The need for HIV related services is of particular concern in South Africa with the highest number of 
infections worldwide.2This has led to the increasing demands on primary health care services for chronic 
services. The scope of practice of nurses who provide the backbone of the primary health care service 
have expanded with the need to provide chronic care. Antenatal care provides an access point for HIV 
related care for pregnant women and their families, and PMTCT programmes need to be strengthened 
for this purpose.Task shifting has allowed the reorganization of the workforce in order to make more 
efficient use of human resources available in order to address the workforce shortage crisis. 44Strong 
leadership and stewardship is required to ensure the successful implementation of proposed HIV-
related policies.  
The identification of weaknesses in the health system and quality concerns can go to inform 
interventions that would target gaps in the provision of care so as to improve service delivery.  The 
Policy for Quality Health Care has highlighted the need to assess issues of access, increase patient 
participation, focus on preventive and promotive activities, increase research on operational 
effectiveness, ensure appropriate use of health care services and reduce adverse events in the health 
care setting. The four main target areas of the interventions included health professionals, patients, the 
community and the health service delivery system.22 The health care system requires an ongoing process 
of monitoring and evaluation a constant evaluation in order to improve quality. Quality improvement 
can be achieved through the capacity building and the sensitization of health care workers, and 
individual and community participation so as to foster a sense of empowerment in addition to ensuring 
that services are catered to the needs of the users.  Improved communication between health care 
workers and patients while ensuring that users receive clear and understandable health related 
information has positive effects on the health status of individuals.  
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Part D:  Appendices 
UNIVERSITY OF CAPE TOWN 
llow-up of TB patients from Guguletu 
28 Sept 2008 
The Chair Ethics Committee 
Faculty of Health Sciences 
University of Cape Town 
Dear Prof Blockman 
Re: Request for amendment to Protocol “PMTCT Effectiveness in Africa: Research and Linkages to 
Care; PART 1 Version 1”  
REC REF: 038/2007 
We request the Ethics Committee review for approval the following amendment to this protocol. We 
request that the approval letter include the following information:  
1) The Title of protocol: Change from Version 1 to Version 2
2) A statement of approval of the amendment to include within the Facility Survey additional
structured observations and exit interviews, after informed consent is obtained in order to
evaluate the quality of antenatal care.
The amendment to the protocol has already been approved by the CDC and the University of Alabama. 
Enclosed herewith is a copy of the amended protocol in track changes, the tools to be used for the 
observations and interviews and the informed consent forms. (list attached).   
Regards 
Dr David Coetzee 
Principal Investigator from UCT 
Director: Infectious Disease Epidemiology Unit, Falmouth Building, Level 1 
Tel: 021406 6262 or Cell: 0824512699 
School of Public Health and Family Medicine 
Infectious Disease Epidemiology Unit 




Telephone:  (27 21)  406 6262 
Fax:       (27 21) 406 6764 
Head of School: Prof. Leslie London 
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Email: david.coetzee@uct.ac.za 
List of attachments: 
1. Face Sheet – Facility survey
2. Module 1: Clinical observation of six consecutive pregnant women consultations
3. Module 1: Informed consent service provider
4. Module 1: Informed consent patient
5. Module 2: Exit interviews
6. Module 2: Informed consent
7. Module 3: Health facility checklist
8. Module 4 Health provider interview
9. Module 3 and 4: Informed consent
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UNIVERSITY OF CA PE TO\,\!N , 
13 October 2008 
REC REF: 038 / 2007 
Or 0 Coetzee 
School of Public Health & Family Medicine 
Dea r Dr Coetzee 
Health Sciences Facuhy 
Research Ethics Committee 
Room E52-24 Groote Schuur Hospital Old Main Building 
Observatory 7925 
Telephone l021] 406 6338 • Facsimile l021] 40664 '11 
e-mail: lam(.es. t~l njt.di@uct. ac.za 
I'ROjECT T ITLE: PMTCT EFFECTIVENESS IN AFRICA: RESEARCH AND LINKAGES TO 
CARE PARTI: CORD BLOOD SURVEILLANCE PROTOCOL VERSION 2.0 
Th:l1lk you for your letter [0 the Research Ethics Committee dated 28 September 2008. 
11 is a ple:lsure to inform Y OLI that the Ethics Comm.inec has al>(1coved the following with reference to the 
above-mentioned study: -
• Title change to version 2: 
• Protocol amended to include within the Facility Survey additional structured observations :\Ild exi t 
interviews after infonncd consent is obtained in order to evaluate the quality of antena tal ca re. 
• Approved the following list of attachments: (as listed 1-9) 
1. Face Sheet- Facility survey 
2. Modllle I: Clinical observation of six com,ecurive pregnant women consultations 
3. i'vlodulel : Infonned cons{~m service provider 
4. J\'lodule I: Infonncd consent patient 
5. Module 2: Exit interviews 
6. Module 2: Info nned consent 
7. Module 3: Health facility checklist 
8. Module 4 :Health provider interview 
9. Module 3 & 4 : In formed consent 
Please no te that the ongoing ethica l conduct of the study remains the responsibility of tht! principal 
inves tigaror. 
PlC~ISC quott: the REC. REF in all yo ur corrcspom)clll.:c. 
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Module 3 & 4: Health care provider interview 
INFORMED CONSENT: service provider 
Facility Code:   Interviewer Code:  
Hello. My name is_________. I am from the School of Public Health and Family Medicine, University of 
Cape Town. I am carrying out a facility-based survey concerning Prevention of Mother-to-Child 
Transmission (PMTCT) services. The aim of this research is to assist the Provincial Government of the 
Western Cape in the provision of improved maternal and child health services, particularly for pregnant 
women infected with HIV. This survey is part of a larger study of PMTCT programmes in the Free State, 
South Africa, as well as programmes operating in Zambia, Cameroon and the Ivory Coast. 
This facility has been selected to participate in the survey and I wish to ask you questions about the 
health services provided here. The data collected will be used for research purposes.The results of this 
study will be presented to the Provincial Government and other organizations supporting health 
services, in order to aid in the planning of further service provision and future research in PMTCT.  
Your name and all information that you give me will be kept strictly confidential.    
No patient names will be reviewed, recorded, or shared. 
You may refuse to answer any question or choose to stop the interview at any time. 
Your particiaption is voluntary. Should you decline the interview or any questions therin, it will not 
prejudice your employment at this or any other health service. 
Do you have any questions about the survey? 
Do I have your agreement to proceed?       YES    NO   (circle response) 
Name of interviewer: 
Initials of interviewee:  







Results Tables  
 
Table 1: 











Location of HIV testing  
Soap availability  
Availability of HIV testing kit 
Quality of location where women are seen for 
privacy  
Availability of Maternal Nevirapine & AZT 
Number of nurses/midwives hired 
Number of nurses/midwives trained in HIV 
testing/PMTCT dispensing 
Organizational Structure Training on range of topics 
Availability of guidelines on range of topics 
Provision of technical support to staff 
Provision of ART at clinic 
Partner HIV testing 
Availability of community support groups 
Process Type of health care provider attending to 
women 
Length of time to get CD4 results 
Gestational age(weeks) when nevirapine 
given 
Educational talks given on range of topics 
Activities done and recorded:  
Blood Pressure  
Palpate 
Listen for fetal heart tone  
Urine dip stick  
Give patients ferrous sulphate 
Outcome Patient satisfaction  















Attribute Free State Western Cape 
N Median IQR N Median IQR 
Number of Nurses Hired 13 4 3-11 5 4 3-6
Number of Midwives 
Hired 
13 3 3-4 5 7 6-13
Number of 
nurses/midwives trained 
in HIV testing 
13 4 3-6 3 4 0-11
Number of 
nurses/midwives trained 
in PMTCT dispensing 
13 3 2-5 3 1 0-4




N % CI N % CI 
Location of HIV testing  
(ANC building vs. other location) 
11 84.62 54.55-98.18 5 100.00 47.82-100.00 
Soap visible at water sources  
(All or Some vs. None) 
8 61.54 31.58-86.14 4 80.00 28.36-99.50 
Items for ANC-HIV testing kit 
(Yes observed vs. not observed) 
13 100.00 75.29-100.00 4 80.00 28.36-99.50 
Quality of location where women are 
seen for privacy 
13 100.00 75.29-100.00 3 60.00 14.66-94.73 
(Visual&Auditory vs. Visual/Not 
Auditory) 
Maternal Nevirapine available 13 100.00 75.29-100.00 2 40.00 5.27-85.33 


















 N % CI N % CI 
Pre/in-service training related to 
maternal, child, newborn health or 
illness during past 3 years? 
12 92.31 63.97-99.81 5 100.00 47.82-100.00 
Received technical support or 
supervision in past 4-6 months 
13 100.00 75.29-100.00 5 100.00 47.82-100.00 
Training Topics (within past 12 months/2-3 years vs. no training) 
Rapid HIV testing  10 76.92 46.19-94.96 5 100.00 47.81-100.00 
Prophylactic drugs to pregnant 
women 
13 100.00 75.29-100.00 4 80.00 28.36-99.50 
Breastfeeding 12 92.31 63.97-99.81 4 80.00 28.36-99.50 
New Born Care 2 15.38 1.92-45.45 5 100.00 47.82-100.00 
Composite Training 
(Training in all of the above topics 
within past 3 years) 
2 15.38 1.92-45.45 3 60.00 14.66-94.73 
Guidelines (observed/reported vs. not available) 
Immunisation 12 92.31 63.97-99.81 5 100.00 47.82-100.00 
Antenatal Care 13 100.00 75.29-100.00 4 80.00 39.76-100.00 
PMTCT 13 100.00 75.29-100.00 5 100.00 47.82-100.00 
Composite Guidelines 
(reported or observed on all of the 
topics including immunisation, 
antenatal care and PMTCT) 
12 92.31 63.97-99.81 4 80.00 39.76-100.00 
Pregnant women offered ART at 
clinic 
6 46.15 19.22-74.87 3 60.00 14.66-94.73 
Husbands/ 
partners offered HIV testing as 
part of the program 
12 92.31 63.97-99.81 4 80.00 28.36-99.50 
HIV support groups for pregnant 
women active in community that 
facility serves 




1) Binomial Exact CI




Facility Specific Elements N % (1)CI N % (1)CI
Type of Health provider attending to 
women 
(Nurse vs. Doctor) 
13 100.00 75.29-100.00 5 100.00 47.82-100 
Length of time to get CD4 results 
(within 1 week vs. between 1-2 weeks) 
12 92.31 63.97-99.81 2 40.00 5.27-85.34 
Gestation (weeks) when nevirapine 
given 
(28-36 weeks vs. at birth) 
11 84.62 54.55-98.08 0 0.00 0.00-52.18 
Educational  Talks given to all women 
HIV 8 61.54 31.58-86.14 1 20.00 0.51-71.64 
Good Antenatal Care 1 7.69 0.19-36.03 1 20.00 0.51-71.64 
Safe Delivery 1 7.69 0.19-36.03 1 20.00 0.51-71.64 
Breastfeeding 6 46.15 19.22-74.87 2 40.00 5.27-85.34 
PMTCT 6 46.15 19.22-74.87 2 40.00 5.27-85.34 
Family Planning 4 30.77 9.09-61.42 1 20.00 0.51-71.64 
Patient Specific Elements P50 IQR P50 IQR 
Activities done and recorded 
Blood Pressure 100.00 100.00-100.00 100.00 83.33-100.00 
Palpate 100.00 100.00-100.00 100.00 83.33-100.00 
Listen for fetal heart tone 100.00 100.00-100.00 100.00 33.33-100.00 
Urine dip stick 100.00 100.00-100.00 100.00 100.00-100.00 






























Good Explanation for reason 
for visit 
97.57 2.56 0.00 0.00 2.56 5 5-5 
30.00 66.76 3.33 0.00 0.00 4 4-5 
Health Facility has everything 
needed for complete care 
28.21 24.36 7.69 21.79 17.95 4 2-5 
23.33 50.00 20.00 6.67 0.00 4 3-4 
Medical care received was 
perfect 
76.92 16.67 1.28 2.56 2.56 5 5-5 
20.00 70.00 10.00 0.00 0.00 4 4-4 
Can afford to come to the 
health facility 
82.05 8.97 0.00 1.28 7.69 5 5-5 
16.67 83.33 0.00 0.00 0.00 4 4-4 
The check up was thorough 79.49 10.26 2.56 6.41 1.28 5 5-5 
33.33 56.67 6.67 3.33 0.00 4 4-4 
It is easy to come to the health 
facility 
84.62 8.97 0.00 3.85 2.56 5 5-5 
23.33 70.00 0.00 6.67 0.00 4 4-4 
The doctors and nurses are 
friendly and courteous 
85.90 12.82 0.00 1.28 0.00 5 5-5 
33.33 66.67 0.00 0.00 0.00 4 4-5 
The doctors and nurses spend 
plenty of time with me 
60.26 23.08 3.85 10.26 2.56 5 4-5 
10.00 56.67 10.00 23.33 0.00 4 3-4 
I can get care whenever I need 
it 
76.92 8.97 5.13 7.69 1.28 5 5-5 










































Unsure if information 
received was correct 
3.85 10.26 2.56 24.36 58.97 5 4-5 
23.33 26.67 33.33 6.67 10.00 2.5 2-3 
I pay more than is affordable 0.00 0.00 0.00 5.13 94.87 5 5-5 
3.45 13.79 0.00 68.97 13.79 4 4-4 
The doctors are rude and 
impersonal 
2.56 8.97 15.38 12.82 60.26 5 3-5 
6.67 6.67 6.67 73.33 6.67 4 4-4 
The doctors and nurses 
hurry through care 
5.13 15.38 1.28 24.36 53.85 5 4-5 
0.00 26.67 6.67 63.33 3.33 4 2-4 
The doctors and nurses 
ignore what I say 
2.56 8.97 2.56 21.79 64.10 5 4-5 
3.45 10.34 17.24 55.17 13.79 4 3-4 
I have doubts about the 
abilities of the doctors and 
nurses 
2.56 12.82 2.56 19.23 62.82 5 4-5 
0.00 6.67 16.67 76.67 0.00 4 4-4 
I am dissatisfied about some 
aspects of care 
8.97 12.82 0.00 29.49 48.72 4 4-5 
3.33 20.00 10.00 66.67 0.00 4 3-4 
 
Table 7 
Patient understanding  
 















 N % CI N % CI 
Correct understanding of 
meds 












Fetal Heart 17.16 0.204 -10.82-45.15




Constant 45.29 0.022 7.87-82.72 
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companies.  
The involvement of medical writers or anyone else who assisted with the 
preparation of the manuscript content should be acknowledged, along with their 
source of funding, as described in the European Medical Writers Association 
(EMWA) guidelines on the role of medical writers in developing peer-reviewed 
publications. If medical writers are not listed among the authors, it is important 
that their role be acknowledged explicitly. We suggest wording such as 'We 
thank Jane Doe who provided medical writing services on behalf of XYZ 
Pharmaceuticals Ltd.'.  
Any 'in press' articles cited within the references and necessary for the reviewers' assessment 
of the manuscript should be made available if requested by the editorial office. 
Submission of a manuscript to BMC Women's Health implies that readily reproducible 
materials described in the manuscript, including all relevant raw data, will be freely available 
to any scientist wishing to use them for non-commercial purposes. Nucleic acid sequences, 
protein sequences, and atomic coordinates should be deposited in an appropriate database in 
time for the accession number to be included in the published article. In computational 
studies where the sequence information is unacceptable for inclusion in databases because of 




Nucleotide sequences can be deposited with the DNA Data Bank of Japan (DDBJ), European 
Molecular Biology Laboratory (EMBL/EBI) Nucleotide Sequence Database, or GenBank 
(National Center for Biotechnology Information). 
Protein sequences  
Protein sequences can be deposited with SwissProt or the Protein Information Resource 
(PIR). 
Structures 
Protein structures can be deposited with one of the members of the Worldwide Protein Data 
Bank. Nucleic Acids structures can be deposited with the Nucleic Acid Database at Rutgers. 
Crystal structures of organic compounds can be deposited with the Cambridge 
Crystallographic Data Centre. 
Chemical structures and assays 
Structures of chemical substances can be deposited with PubChem Substance. Bioactivity 
screens of chemical substances can be deposited with PubChem BioAssay. 
Microarray data 
Where appropriate, authors should adhere to the standards proposed by the Microarray Gene 
Expression Data Society and must deposit microarray data in one of the public repositories, 
such as ArrayExpress, Gene Expression Omnibus (GEO) or the Center for Information 
Biology Gene Expression Database (CIBEX).  
Computional modeling 
We encourage authors to prepare models of biochemical reaction networks using the Systems 
Biology Markup Language and to deposit the model with the BioModels database, as well as 
submitting it as an additional file with the manuscript. 
Plasmids 
We encourage authors to deposit copies of their plasmids as DNA or bacterial stocks with 
Addgene, a non-profit repository, or PlasmID, the Plasmid Information Database at Harvard. 






have appealed against a rejection but remain concerned about the editorial process can refer 
their case to COPE. For more information, visit http://www.publicationethics.org/.  
BioMed Central endorses the World Association of Medical Editors (WAME) Policy 
Statement on Geopolitical Intrusion on Editorial Decisions.  
return to top  
Preparing main manuscript text  
File formats  
 
The following word processor file formats are acceptable for the main manuscript 
document:  
 Microsoft Word (version 2 and above)  
 Rich text format (RTF)  
 Portable document format (PDF)  
 TeX/LaTeX (use BioMed Central's TeX template)  
 DeVice Independent format (DVI)  
 Publicon Document (NB) 
Users of other word processing packages should save or convert their files to 
RTF before uploading. Many free tools are available which ease this process. 
TeX/LaTeX users: We recommend using BioMed Central's TeX template and 
BibTeX stylefile. If you use this standard format, you can submit your 
manuscript in TeX format (after you submit your TEX file, you will be prompted 
to submit your BBL file). If you have used another template for your manuscript, 
or if you do not wish to use BibTeX, then please submit your manuscript as a 
DVI file. We do not recommend converting to RTF.  
Note that figures must be submitted as separate image files, not as part of the 
submitted DOC/ PDF/TEX/DVI file.  
Article types  
 
When submitting your manuscript, you will be asked to assign one of the 
following types to your article:  
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Research article  




Study protocol  
Technical advance 
Please read the descriptions of each of the article types, choose which is 
appropriate for your article and structure it accordingly. If in doubt, your 
manuscript should be classified as a Research article, the structure for which is 
described below.  
Manuscript sections for Research articles 
Manuscripts for Research articles submitted to BMC Women's Health should be 
divided into the following sections:  







List of abbreviations used (if any) 
Competing interests  
Authors' contributions  
Authors' information (if any)  
Acknowledgements and Funding 
References  
Figure legends (if any)  
Tables and captions (if any)  
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Description of additional data files (if any) 
You can download a template (compatible with Mac and Windows Word 
97/98/2000/2003/2007) for your article. For instructions on use, see below. 
The Accession Numbers of any nucleic acid sequences, protein sequences or 
atomic coordinates cited in the manuscript should be provided, in square 
brackets and include the corresponding database name; for example, 
[EMBL:AB026295, EMBL:AC137000, DDBJ:AE000812, GenBank:U49845, 
PDB:1BFM, Swiss-Prot:Q96KQ7, PIR:S66116]. 
The databases for which we can provide direct links are: EMBL Nucleotide 
Sequence Database (EMBL), DNA Data Bank of Japan (DDBJ ), GenBank at the 
NCBI (GenBank), Protein Data Bank (PDB), Protein Information Resource (PIR) 
and the Swiss-Prot Protein Database (Swiss-Prot). 
Title page 
This should list the title of the article. The title should include the study design, 
for example:  
A versus B in the treatment of C: a randomized controlled trial 
X is a risk factor for Y: a case control study  
The full names, institutional addresses, and e-mail addresses for all authors 
must be included on the title page. The corresponding author should also be 
indicated.  
Abstract 
The abstract of the manuscript should not exceed 350 words and must be 
structured into separate sections: Background, the context and purpose of the 
study; Methods, how the study was performed and statistical tests used; 
Results, the main findings; Conclusions, brief summary and potential 
implications. Please minimize the use of abbreviations and do not cite references 
in the abstract; Trial registration, if your research article reports the results of 
a controlled health care intervention, please list your trial registry, along with 
the unique identifying number, e.g. Trial registration: Current Controlled Trials 
ISRCTN73824458. Please note that there should be no space between the letters 
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and numbers of your trial registration number. 
Background  
The background section should be written from the standpoint of researchers 
without specialist knowledge in that area and must clearly state - and, if helpful, 
illustrate - the background to the research and its aims. Reports of clinical 
research should, where appropriate, include a summary of a search of the 
literature to indicate why this study was necessary and what it aimed to 
contribute to the field. The section should end with a very brief statement of 
what is being reported in the article.  
Methods 
This should include the design of the study, the setting, the type of participants 
or materials involved, a clear description of all interventions and comparisons, 
and the type of analysis used, including a power calculation if appropriate.  
Results and Discussion 
The Results and Discussion may be combined into a single section or presented 
separately. Results of statistical analysis should include, where appropriate, 
relative and absolute risks or risk reductions, and confidence intervals. The 
results and discussion sections may also be broken into subsections with short, 
informative headings. 
Conclusions 
This should state clearly the main conclusions of the research and give a clear 
explanation of their importance and relevance. Summary illustrations may be 
included. 
List of abbreviations 
If abbreviations are used in the text, either they should be defined in the text 
where first used, or a list of abbreviations can be provided, which should precede 
the competing interests and authors' contributions.  
Competing interests 
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A competing interest exists when your interpretation of data or presentation of 
information may be influenced by your personal or financial relationship with 
other people or organizations. Authors should disclose any financial competing 
interests but also any non-financial competing interests that may cause them 
embarrassment were they to become public after the publication of the 
manuscript.  
Authors are required to complete a declaration of competing interests. All 
competing interests that are declared will be listed at the end of published 
articles. Where an author gives no competing interests, the listing will read 'The 
author(s) declare that they have no competing interests'.  
When completing your declaration, please consider the following questions: 
Financial competing interests  
In the past five years have you received reimbursements, fees, funding, 
or salary from an organization that may in any way gain or lose financially 
from the publication of this manuscript, either now or in the future? Is 
such an organization financing this manuscript (including the article-
processing charge)? If so, please specify.  
Do you hold any stocks or shares in an organization that may in any way 
gain or lose financially from the publication of this manuscript, either now 
or in the future? If so, please specify.  
Do you hold or are you currently applying for any patents relating to the 
content of the manuscript? Have you received reimbursements, fees, 
funding, or salary from an organization that holds or has applied for 
patents relating to the content of the manuscript? If so, please specify.  
Do you have any other financial competing interests? If so, please specify. 
Non-financial competing interests 
Are there any non-financial competing interests (political, personal, religious, ideological, 
academic, intellectual, commercial or any other) to declare in relation to this manuscript? If 
so, please specify. 
If you are unsure as to whether you or one of your co-authors has a competing interest, please 
discuss it with the editorial office.  
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Authors' contributions 
In order to give appropriate credit to each author of a paper, the individual 
contributions of authors to the manuscript should be specified in this section. 
An "author" is generally considered to be someone who has made substantive intellectual 
contributions to a published study. To qualify as an author one should 1) have made 
substantial contributions to conception and design, or acquisition of data, or analysis and 
interpretation of data; 2) have been involved in drafting the manuscript or revising it critically 
for important intellectual content; and 3) have given final approval of the version to be 
published. Each author should have participated sufficiently in the work to take public 
responsibility for appropriate portions of the content. Acquisition of funding, collection of 
data, or general supervision of the research group, alone, does not justify authorship. 
We suggest the following kind of format (please use initials to refer to each author's 
contribution): AB carried out the molecular genetic studies, participated in the sequence 
alignment and drafted the manuscript. JY carried out the immunoassays. MT participated in 
the sequence alignment. ES participated in the design of the study and performed the 
statistical analysis. FG conceived of the study, and participated in its design and coordination 
and helped to draft the manuscript. All authors read and approved the final manuscript. 
All contributors who do not meet the criteria for authorship should be listed in an 
acknowledgements section. Examples of those who might be acknowledged include a person 
who provided purely technical help, writing assistance, or a department chair who provided 
only general support. 
Authors' information 
You may choose to use this section to include any relevant information about the 
author(s) that may aid the reader’s interpretation of the article, and understand 
the standpoint of the author(s). This may include details about the authors' 
qualifications, current positions they hold at institutions or societies, or any other 
relevant background information. Please refer to authors using their initials. Note 
this section should not be used to describe any competing interests.  
Acknowledgements and Funding 
Please acknowledge anyone who contributed towards the study by making 
substantial contributions to conception, design, acquisition of data, or analysis 
and interpretation of data, or who was involved in drafting the manuscript or 
revising it critically for important intellectual content, but who does not meet the 
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criteria for authorship. Please also include their source(s) of funding. Please also 
acknowledge anyone who contributed materials essential for the study. 
The role of a medical writer must be included in the acknowledgements section, 
including their source(s) of funding. 
Authors should obtain permission to acknowledge from all those mentioned in 
the Acknowledgements. 
Please list the source(s) of funding for the study, for each author, and for the 
manuscript preparation in the acknowledgements section. Authors must describe 
the role of the funding body, if any, in study design; in the collection, analysis, 
and interpretation of data; in the writing of the manuscript; and in the decision 
to submit the manuscript for publication.  
References 
All references must be numbered consecutively, in square brackets, in the order 
in which they are cited in the text, followed by any in tables or legends. 
Reference citations should not appear in titles or headings. Each reference must 
have an individual reference number. Please avoid excessive referencing. If 
automatic numbering systems are used, the reference numbers must be 
finalized and the bibliography must be fully formatted before submission.  
Only articles and abstracts that have been published or are in press, or are 
available through public e-print/preprint servers, may be cited; unpublished 
abstracts, unpublished data and personal communications should not be included 
in the reference list, but may be included in the text and referred to as 
"unpublished data", "unpublished observations", or "personal communications" 
giving the names of the involved researchers. Notes/footnotes are not allowed. 
Obtaining permission to quote personal communications and unpublished data 
from the cited author(s) is the responsibility of the author. Journal abbreviations 
follow Index Medicus/MEDLINE. Citations in the reference list should contain all 
named authors, regardless of how many there are.  
Examples of the BMC Women's Health reference style are shown below. Please 
take care to follow the reference style precisely; references not in the correct 
style may be retyped, necessitating tedious proofreading.  
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Links 
Web links and URLs should be included in the reference list. They should be 
provided in full, including both the title of the site and the URL, in the following 
format: The Mouse Tumor Biology Database 
[http://tumor.informatics.jax.org/mtbwi/index.do]  
BMC Women's Health reference style  
Style files are available for use with popular bibliographic management software: 
BibTeX  
EndNote style file  
Reference Manager 
Article within a journal 
1. Koonin EV, Altschul SF, Bork P: BRCA1 protein products: functional
motifs. Nat Genet 1996, 13:266-267.
Article within a journal supplement 
2. Orengo CA, Bray JE, Hubbard T, LoConte L, Sillitoe I: Analysis and
assessment of ab initio three-dimensional prediction, secondary
structure, and contacts prediction. Proteins 1999, 43(Suppl 3):149-170.
In press article 
3. Kharitonov SA, Barnes PJ: Clinical aspects of exhaled nitric oxide. Eur
Respir J, in press.
Published abstract 
4. Zvaifler NJ, Burger JA, Marinova-Mutafchieva L, Taylor P, Maini RN:
Mesenchymal cells, stromal derived factor-1 and rheumatoid arthritis
[abstract]. Arthritis Rheum 1999, 42:s250.






5. Jones X: Zeolites and synthetic mechanisms. In Proceedings of the First 
National Conference on Porous Sieves: 27-30 June 1996; Baltimore. Edited by 
Smith Y. Stoneham: Butterworth-Heinemann; 1996:16-27.  
Book chapter, or article within a book  
 
6. Schnepf E: From prey via endosymbiont to plastids: comparative 
studies in dinoflagellates. In Origins of Plastids. Volume 2. 2nd edition. Edited 
by Lewin RA. New York: Chapman and Hall; 1993:53-76.  
Whole issue of journal  
 
7. Ponder B, Johnston S, Chodosh L (Eds): Innovative oncology. In Breast 
Cancer Res 1998, 10:1-72.  
Whole conference proceedings  
 
8. Smith Y (Ed): Proceedings of the First National Conference on Porous Sieves: 
27-30 June 1996; Baltimore. Stoneham: Butterworth-Heinemann; 1996.  
Complete book  
 
9. Margulis L: Origin of Eukaryotic Cells. New Haven: Yale University Press; 
1970.  
Monograph or book in a series  
 
10. Hunninghake GW, Gadek JE: The alveolar macrophage. In Cultured 
Human Cells and Tissues. Edited by Harris TJR. New York: Academic Press; 
1995:54-56. [Stoner G (Series Editor): Methods and Perspectives in Cell Biology, 
vol 1.]  
Book with institutional author  
 
11. Advisory Committee on Genetic Modification: Annual Report. London; 1999.  
PhD thesis  
 
12. Kohavi R: Wrappers for performance enhancement and oblivious 
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decision graphs. PhD thesis. Stanford University, Computer Science 
Department; 1995.  
Link / URL 
13. The Mouse Tumor Biology Database
[http://tumor.informatics.jax.org/mtbwi/index.do]
Microsoft Word template
Although we can accept manuscripts prepared as Microsoft Word, RTF or PDF 
files, we have designed a Microsoft Word template that can be used to generate 
a standard style and format for your article. It can be used if you have not yet 
started to write your paper, or if it is already written and needs to be put into 
BMC Women's Health style. 
Download the template (Mac and Windows compatible Word 1998/2000) from 
our site, and save it to your hard drive. Double click the template to open it. 
How to use the BMC Women's Health template 
The template consists of a standard set of headings that make up a BMC 
Women's Health Research article manuscript, along with dummy fragments of 
body text. Follow these steps to create your manuscript in the standard format: 
Replace the dummy text for Title, Author details, Institutional affiliations, 
and the other sections of the manuscript with your own text (either by 
entering the text directly or by cutting and pasting from your own 
manuscript document).  
If there are sections which you do not need, delete them (but check the 
rest of the Instructions for Authors to see which sections are compulsory). 
If you need an additional copy of a heading (e.g. for additional figure 
legends) just copy and paste.  
For the references, you may either manually enter the references using 
the reference style given, or use bibliographic software to insert them 






For extra convenience, you can use the template as one of your standard Word 
templates. To do this, put a copy of the template file in Word's 'Templates' 
folder, normally C:\Program Files\Microsoft Office\Templates on a PC. The next 
time you create a new document in Word using the File menu, the template will 
appear as one of the available choices for a new document.  
return to top  
Preparing illustrations and figures  
Figures should be provided as separate files. Each figure should comprise only a 
single file. There is no charge for the use of color.  
Please read our figure preparation guidelines for detailed instructions on 
maximising the quality of your figures,  
Formats  
 
The following file formats can be accepted:  
 EPS (preferred format for diagrams)  
 PDF (also especially suitable for diagrams)  
 PNG (preferred format for photos or images)  
 Microsoft Word (figures must be a single page)  
 PowerPoint (figures must be a single page)  
 TIFF  
 JPEG  
 BMP  
 CDX (ChemDraw)  
 TGF (ISIS/Draw) 
Figure legends  
 
The legends should be included in the main manuscript text file rather than being a 
part of the figure file. For each figure, the following information should be provided: 
Figure number (in sequence, using Arabic numerals - i.e. Figure 1, 2, 3 etc); short 
title of figure (maximum 15 words); detailed legend, up to 300 words.  
Please note that it is the responsibility of the author(s) to obtain 
permission from the copyright holder to reproduce figures or tables that have 
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previously been published elsewhere. 
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Preparing tables 
Each table should be numbered in sequence using Arabic numerals (i.e. Table 1, 2, 
3 etc.). Tables should also have a title that summarizes the whole table, maximum 
15 words. Detailed legends may then follow, but should be concise. 
Smaller tables considered to be integral to the manuscript can be pasted into the 
document text file, in portrait format (note that tables on a landscape page must 
be reformatted onto a portrait page or submitted as additional files). These will be 
typeset and displayed in the final published form of the article. Such tables should 
be formatted using the 'Table object' in a word processing program to ensure that 
columns of data are kept aligned when the file is sent electronically for review; this 
will not always be the case if columns are generated by simply using tabs to 
separate text. Commas should not be used to indicate numerical values. Color and 
shading should not be used.  
Larger datasets can be uploaded separately as additional files. Additional files will 
not be displayed in the final, published form of the article, but a link will be 
provided to the files as supplied by the author. 
Tabular data provided as additional files can be uploaded as an Excel spreadsheet 
(.xls) or comma separated values (.csv). As with all files, please use the standard 
file extensions. 
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Preparing additional files 
Although BMC Women's Health does not restrict the length and quantity of data in 
a paper, there may still be occasions where an author wishes to provide data sets, 
tables, movie files, or other information as additional information. These files can 
be uploaded using the 'Additional Material files' button in the manuscript 
submission process.  
The maximum file size for additional files is 20 MB each, and files will be virus-
scanned on submission. 
Any additional files will be linked into the final published article in the form supplied 
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by the author, but will not be displayed within the paper. They will be made 
available in exactly the same form as originally provided. 
If additional material is provided, please list the following information in a separate 
section of the manuscript text, at the end of the document text file: 
File name  
File format (including name and a URL of an appropriate viewer if format is 
unusual)  
Title of data  
Description of data 
Additional datafiles should be referenced explicitly by file name within the body of 
the article, e.g. 'See additional file 1: Movie1 for the original data used to perform 
this analysis'. 
Formats and uploading
Ideally, file formats for additional files should not be platform-specific, and should 
be viewable using free or widely available tools. The following are examples of 
suitable formats.  
Additional documentation 
o PDF (Adobe Acrobat)
Animations 





o XLS (Excel spreadsheet)
o CSV (Comma separated values)
As with figure files, files should be given the standard file extensions. This is 
especially important for Macintosh users, since the Mac OS does not enforce the 
use of standard extensions. Please also make sure that each additional file is a 
single table, figure or movie (please do not upload linked worksheets or PDF files 
larger than one sheet). 
Mini-websites
85 
Small self-contained websites can be submitted as additional files, in such a way 
that they will be browsable from within the full text HTML version of the article. In 
order to do this, please follow these instructions: 
1. Create a folder containing a starting file called index.html (or index.htm) in
the root
2. Put all files necessary for viewing the mini-website within the folder, or sub-
folders
3. Ensure that all links are relative (ie "images/picture.jpg" rather than
"/images/picture.jpg" or "http://yourdomain.net/images/picture.jpg" or
"C:\Documents and Settings\username\My Documents\mini-
website\images\picture.jpg") and no link is longer than 255 characters
4. Access the index.html file and browse around the mini-website, to ensure
that the most commonly used browsers (Internet Explorer and Firefox) are
able to view all parts of the mini-website without problems, it is ideal to
check this on a different machine
5. Compress the folder into a ZIP, check the file size is under 20 MB, ensure
that index.html is in the root of the ZIP, and that the file has .zip extension,
then submit as an additional file with your article
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Style and language 
General
Currently, BMC Women's Health can only accept manuscripts written in English. 
Spelling should be US English or British English, but not a mixture.  
Gene names should be in italic, but protein products should be in plain type. 
There is no explicit limit on the length of articles submitted, but authors are 
encouraged to be concise. There is no restriction on the number of figures, tables 
or additional files that can be included with each article online. Figures and tables 
should be sequentially referenced. Authors should include all relevant supporting 
data with each article.  
BMC Women's Health will not edit submitted manuscripts for style or language; 
reviewers may advise rejection of a manuscript if it is compromised by grammatical 






checked by colleagues before submission. In-house copyediting will be minimal. 
Non-native speakers of English may choose to make use of a copyediting service.  
Help and advice on scientific writing  
 
The abstract is one of the most important parts of a manuscript. For guidance, 
please visit our page on "Writing titles and abstracts for scientific articles"  
 
Tim Albert has produced for BioMed Central a list of tips for writing a scientific 
manuscript. MedBioWorld also provides a list of resources for science writing.  
Abbreviations  
 
Abbreviations should be used as sparingly as possible. They can be defined when 
first used or a list of abbreviations can be provided preceding the 
acknowledgements and references.  
Typography  
 Please use double line spacing.  
 Type the text unjustified, without hyphenating words at line breaks.  
 Use hard returns only to end headings and paragraphs, not to rearrange 
lines.  
 Capitalize only the first word, and proper nouns, in the title.  
 All pages should be numbered.  
 Use the BMC Women's Health reference format.  
 Footnotes to text should not be used.  
 Greek and other special characters may be included. If you are unable to 
reproduce a particular special character, please type out the name of the 
symbol in full.  
 
Please ensure that all special characters used are embedded in the 
text, otherwise they will be lost during conversion to PDF.  
 Genes, mutations, genotypes, and alleles should be indicated in italics, and 
authors are required to use approved gene symbols, names, and formatting. 
Protein products should be in plain type. 
Units  
 
SI Units should be used throughout (liter and molar are permitted, however).  
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